Kimball Electronics, Inc. - FORM 10-Q - May 5, 2020

Attached files

file filename
EX-31.2 - KIMBALL ELECTRONICS, INC. EXHIBIT 31.2 - Kimball Electronics, Inc.exhibit31203312020q310q.htm
EX-32.2 - KIMBALL ELECTRONICS, INC. EXHIBIT 32.2 - Kimball Electronics, Inc.exhibit32203312020q310q.htm
EX-32.1 - KIMBALL ELECTRONICS, INC. EXHIBIT 32.1 - Kimball Electronics, Inc.exhibit32103312020q310q.htm
EX-31.1 - KIMBALL ELECTRONICS, INC. EXHIBIT 31.1 - Kimball Electronics, Inc.exhibit31103312020q310q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
x  QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2020
OR
o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number    001-36454
keilogoonelinecolorcmyk2revi.jpg
KIMBALL ELECTRONICS, INC.
(Exact name of registrant as specified in its charter)
Indiana
 
35-2047713
(State or other jurisdiction of
 
(I.R.S. Employer Identification No.)
incorporation or organization)
 
 
1205 Kimball Boulevard, Jasper, Indiana
 
47546
(Address of principal executive offices)
 
(Zip Code)
(812) 634-4000
Registrant’s telephone number, including area code
Not Applicable
Former name, former address and former fiscal year, if changed since last report
Securities registered pursuant to Section 12(b) of the Act:
Title of each Class
Trading Symbol
Name of each exchange on which registered
Common Stock, no par value
KE
The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  
Yes  x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (Section 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).
Yes  x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company.  See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer  o
Accelerated filer  x
Emerging growth company  o
Non-accelerated filer  o         
Smaller reporting company  o
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 
Yes  o    No  x

The number of shares outstanding of the Registrant’s common stock as of April 22, 2020 was 24,987,321 shares.



KIMBALL ELECTRONICS, INC.
FORM 10-Q
INDEX
 
Page No.
 
 
 
 
PART I    FINANCIAL INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PART II    OTHER INFORMATION
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

2


PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

KIMBALL ELECTRONICS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Amounts in Thousands, Except for Share Data)
 
(Unaudited)
 
 

 
March 31,
2020
 
June 30,
2019
ASSETS
 

 
 

Current Assets:
 

 
 

Cash and cash equivalents
$
58,312

 
$
49,276

Receivables, net of allowances of $365 and $270, respectively
191,343

 
225,555

Contract assets
69,474

 
51,929

Inventories
198,961

 
203,840

Prepaid expenses and other current assets
25,374

 
24,713

Total current assets
543,464

 
555,313

Property and Equipment, net of accumulated depreciation of $230,723 and $216,955, respectively
145,958

 
143,629

Goodwill
19,936

 
18,104

Other Intangible Assets, net of accumulated amortization of $31,933 and $29,874, respectively
20,003

 
22,188

Other Assets
28,889

 
24,877

Total Assets
$
758,250

 
$
764,111

 
 
 
 
LIABILITIES AND SHARE OWNERS’ EQUITY
 
 
 
Current Liabilities:
 
 
 
Current portion of borrowings under credit facilities
$
30,901

 
$
34,713

Accounts payable
191,551

 
197,001

Accrued expenses
39,611

 
43,196

Total current liabilities
262,063

 
274,910

Other Liabilities:
 
 
 
Long-term debt under credit facilities, less current portion
91,500

 
91,500

Long-term income taxes payable
9,765

 
9,765

Other long-term liabilities
19,534

 
18,082

Total other liabilities
120,799

 
119,347

Share Owners’ Equity:
 
 
 
Preferred stock-no par value
 
 
 
Shares authorized: 15,000,000
Shares issued: None
—

 
—

Common stock-no par value
 
 
 
Shares authorized: 150,000,000
Shares issued: 29,430,000
—

 
—

Additional paid-in capital
305,906

 
305,917

Retained earnings
153,451

 
133,982

Accumulated other comprehensive loss
(14,899
)
 
(7,628
)
Treasury stock, at cost:

 

Shares: 4,443,000 and 4,011,000, respectively
(69,070
)
 
(62,417
)
Total Share Owners’ Equity
375,388

 
369,854

Total Liabilities and Share Owners’ Equity
$
758,250

 
$
764,111



3


KIMBALL ELECTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Amounts in Thousands, Except for Per Share Data)
 
 
 
 
 
Three Months Ended
 
Nine Months Ended
 
March 31
 
March 31
(Unaudited)
2020
 
2019
 
2020
 
2019
Net Sales
$
293,925

 
$
313,454

 
$
914,394

 
$
863,223

Cost of Sales
273,713

 
286,900

 
851,478

 
798,039

Gross Profit
20,212

 
26,554

 
62,916

 
65,184

Selling and Administrative Expenses
9,624

 
12,057

 
32,529

 
33,535

Other General Income
—

 
—

 
—

 
(92
)
Operating Income
10,588

 
14,497

 
30,387

 
31,741

Other Income (Expense):
 
 
 
 
 
 
 
Interest income
18

 
19

 
43

 
42

Interest expense
(1,166
)
 
(1,165
)
 
(3,523
)
 
(2,644
)
Non-operating income (expense), net
(745
)
 
1,323

 
(672
)
 
632

Other income (expense), net
(1,893
)
 
177

 
(4,152
)
 
(1,970
)
Income Before Taxes on Income
8,695

 
14,674

 
26,235

 
29,771

Provision for Income Taxes
2,436

 
2,825

 
6,766

 
5,738

Net Income
$
6,259

 
$
11,849

 
$
19,469

 
$
24,033

 
 
 
 
 
 
 
 
Earnings Per Share of Common Stock:
 

 
 

 
 
 
 
Basic
$
0.25

 
$
0.46

 
$
0.77

 
$
0.92

Diluted
$
0.25

 
$
0.46

 
$
0.76

 
$
0.92

 
 
 
 
 
 
 
 
Average Number of Shares Outstanding:
 
 
 
 
 
 
 
Basic
25,181

 
25,479

 
25,308

 
25,993

Diluted
25,287

 
25,568

 
25,466

 
26,181




4


KIMBALL ELECTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Amounts in Thousands)
 
Three Months Ended
 
Three Months Ended
 
March 31, 2020
 
March 31, 2019
(Unaudited)
Pre-tax
 
Tax
 
Net of Tax
 
Pre-tax
 
Tax
 
Net of Tax
Net income
 
 
 
 
$
6,259

 
 
 
 
 
$
11,849

Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
$
(1,802
)
 
$
—

 
$
(1,802
)
 
$
(1,693
)
 
$
—

 
$
(1,693
)
Postemployment severance actuarial change
44

 
(14
)
 
30

 
61

 
(15
)
 
46

Derivative gain (loss)
(5,171
)
 
1,164

 
(4,007
)
 
748

 
(161
)
 
587

Reclassification to (earnings) loss:
 
 
 
 
 
 
 
 
 
 
 
Derivatives
(124
)
 
25

 
(99
)
 
(561
)
 
110

 
(451
)
Amortization of actuarial change
(100
)
 
24

 
(76
)
 
(120
)
 
29

 
(91
)
Other comprehensive income (loss)
$
(7,153
)
 
$
1,199

 
$
(5,954
)
 
$
(1,565
)
 
$
(37
)
 
$
(1,602
)
Total comprehensive income
 
 
 
 
$
305

 
 
 
 
 
$
10,247

 
 
 
 
 
 
 
 
 
 
 
 
 
Nine Months Ended
 
Nine Months Ended
 
March 31, 2020
 
March 31, 2019
(Unaudited)
Pre-tax
 
Tax
 
Net of Tax
 
Pre-tax
 
Tax
 
Net of Tax
Net income
 
 
 
 
$
19,469

 
 
 
 
 
$
24,033

Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Foreign currency translation adjustments
$
(3,004
)
 
$
—

 
$
(3,004
)
 
$
(3,717
)
 
$
—

 
$
(3,717
)
Postemployment severance actuarial change
(190
)
 
55

 
(135
)
 
371

 
(89
)
 
282

Derivative gain (loss)
(3,592
)
 
835

 
(2,757
)
 
2,487

 
(517
)
 
1,970

Reclassification to (earnings) loss:
 
 
 
 
 
 
 
 
 
 
 
Derivatives
(1,434
)
 
290

 
(1,144
)
 
(546
)
 
94

 
(452
)
Amortization of actuarial change
(305
)
 
74

 
(231
)
 
(348
)
 
84

 
(264
)
Other comprehensive income (loss)
$
(8,525
)
 
$
1,254

 
$
(7,271
)
 
$
(1,753
)
 
$
(428
)
 
$
(2,181
)
Total comprehensive income
 
 
 
 
$
12,198

 
 
 
 
 
$
21,852

 
 
 
 
 
 
 
 
 
 
 
 


5


KIMBALL ELECTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Amounts in Thousands)
 
 
 
Nine Months Ended
 
March 31
(Unaudited)
2020
 
2019
Cash Flows From Operating Activities:
 
 
 
Net income
$
19,469

 
$
24,033

Adjustments to reconcile net income to net cash provided by (used for) operating activities:
 
 
Depreciation and amortization
22,883

 
21,487

(Gain) loss on sales of assets
38

 
(6
)
Deferred income tax and other deferred charges
5

 
(1,846
)
Deferred tax valuation allowance
356

 
(410
)
Stock-based compensation
3,123

 
4,261

Other, net
(210
)
 
(278
)
Change in operating assets and liabilities:
 
 
 
Receivables
33,614

 
(37,399
)
Contract assets
(17,545
)
 
(8,981
)
Inventories
4,469

 
(43,786
)
Prepaid expenses and other assets
(2,495
)
 
(4,560
)
Accounts payable
(4,314
)
 
24,339

Accrued expenses and taxes payable
(8,075
)
 
4,166

Net cash provided by (used for) operating activities
51,318

 
(18,980
)
Cash Flows From Investing Activities:
 
 
 
Capital expenditures
(27,533
)
 
(15,238
)
Proceeds from sales of assets
98

 
467

Payments for acquisitions, net of cash acquired
—

 
(43,889
)
Purchases of capitalized software
(235
)
 
(792
)
Other, net
68

 
(12
)
Net cash used for investing activities
(27,602
)
 
(59,464
)
Cash Flows From Financing Activities:
 
 
 
Proceeds from credit facilities
—

 
91,500

Payments on credit facilities
—

 
(12,843
)
Additional net change in revolving credit facilities
(3,683
)
 
27,300

Repurchases of common stock
(8,794
)
 
(23,431
)
Payments related to tax withholding for stock-based compensation
(1,012
)
 
(1,766
)
Debt issuance costs
—

 
(445
)
Net cash (used for) provided by financing activities
(13,489
)
 
80,315

Effect of Exchange Rate Change on Cash and Cash Equivalents
(1,191
)
 
(1,149
)
Net Increase in Cash and Cash Equivalents
9,036

 
722

Cash and Cash Equivalents at Beginning of Period
49,276

 
46,428

Cash and Cash Equivalents at End of Period
$
58,312

 
$
47,150

Supplemental Disclosure of Cash Flow Information
 
 
 
Cash paid during the period for:
 
 
 
Income taxes
$
7,924

 
$
7,453

Interest expense
$
3,736

 
$
1,765



6


KIMBALL ELECTRONICS, INC.
CONDENSED CONSOLIDATED STATEMENT OF SHARE OWNERS’ EQUITY
(Amounts in Thousands, Except for Share Data)
 
Three Months Ended
 
 
 
Retained Earnings
 
Accumulated Other Comprehensive Income (Loss)
 
Treasury Stock
 
Total Share Owners’ Equity
(Unaudited)
Additional Paid-In Capital
 
Amounts at December 31, 2019
$
305,041

 
$
147,192

 
$
(8,945
)
 
$
(66,450
)
 
$
376,838

Net income
 
 
6,259

 
 
 
 
 
6,259

Other comprehensive income (loss)
 
 
 
 
(5,954
)
 
 
 
(5,954
)
Compensation expense related to stock compensation plans
908

 
 
 
 
 
—

 
908

Performance share issuance (3,000 shares)
(11
)
 
 
 
 
 
34

 
23

Deferred share issuance (3,000 shares)
(32
)
 
 
 
 
 
32

 
—

Repurchase of Common Stock (214,000 shares)
 
 
 
 
 
 
(2,686
)
 
(2,686
)
Amounts at March 31, 2020
$
305,906

 
$
153,451

 
$
(14,899
)
 
$
(69,070
)
 
$
375,388

 
 
 
 
 
 
 
 
 
 
Amounts at December 31, 2018
$
303,125

 
$
114,608

 
$
(7,478
)
 
$
(57,678
)
 
$
352,577

Net income
 
 
11,849

 
 
 
 
 
11,849

Other comprehensive income (loss)
 
 
 
 
(1,602
)
 
 
 
(1,602
)
Compensation expense related to stock compensation plans
1,390

 
 
 
 
 
 
 
1,390

Repurchase of Common Stock (295,000 shares)
 
 
 
 
 
 
(4,739
)
 
(4,739
)
Amounts at March 31, 2019
$
304,515

 
$
126,457

 
$
(9,080
)
 
$
(62,417
)
 
$
359,475

 
Nine Months Ended
 
 
 
Retained Earnings
 
Accumulated Other Comprehensive Income (Loss)
 
Treasury Stock
 
Total Share Owners’ Equity
(Unaudited)
Additional Paid-In Capital
 
Amounts at June 30, 2019
$
305,917

 
$
133,982

 
$
(7,628
)
 
$
(62,417
)
 
$
369,854

Net income
 
 
19,469

 
 
 
 
 
19,469

Other comprehensive income (loss)
 
 
 
 
(7,271
)
 
 
 
(7,271
)
Issuance of non-restricted stock (4,000 shares)
22

 
 
 
 
 
48

 
70

Compensation expense related to stock compensation plans
3,046

 
 
 
 
 
 
 
3,046

Performance share issuance (184,000 shares)
(3,047
)
 
 
 
 
 
2,061

 
(986
)
Deferred share issuance (3,000 shares)
(32
)
 
 
 
 
 
32

 
—

Repurchase of Common Stock (623,000 shares)
 
 
 
 
 
 
(8,794
)
 
(8,794
)
Amounts at March 31, 2020
$
305,906

 
$
153,451

 
$
(14,899
)
 
$
(69,070
)
 
$
375,388

 
 
 
 
 
 
 
 
 
 
Amounts at June 30, 2018
$
304,215

 
$
99,374

 
$
(6,899
)
 
$
(41,163
)
 
$
355,527

Net income
 
 
24,033

 
 
 
 
 
24,033

Other comprehensive income (loss)
 
 
 
 
(2,181
)
 
 
 
(2,181
)
Cumulative effect of accounting change
 
 
3,050

 
 
 
 
 
3,050

Issuance of non-restricted stock (4,000 shares)
28

 
 
 
 
 
44

 
72

Compensation expense related to stock compensation plans
4,167

 
 
 
 
 
 
 
4,167

Performance share issuance (203,000 shares)
(3,895
)
 
 
 
 
 
2,133

 
(1,762
)
Repurchase of Common Stock (1,320,000 shares)
 
 
 
 
 
 
(23,431
)
 
(23,431
)
Amounts at March 31, 2019
$
304,515

 
$
126,457

 
$
(9,080
)
 
$
(62,417
)
 
$
359,475

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  



7


KIMBALL ELECTRONICS, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Note 1. Business Description and Summary of Significant Accounting Policies
Business Description:
Kimball Electronics, Inc. (also referred to herein as “Kimball Electronics,” the “Company,” “we,” “us,” or “our”) is a global, multifaceted manufacturing solutions provider. We provide contract electronics manufacturing services (“EMS”) and diversified manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end markets. We offer a package of value that begins with our core competency of producing “durable electronics” and includes our set of robust processes and procedures that help us ensure that we deliver the highest levels of quality, reliability, and service throughout the entire life cycle of our customers’ products. We further offer diversified contract manufacturing services for non-electronic components, medical disposables, precision molded plastics, and production automation, test, and inspection equipment. We are well recognized by customers and industry trade publications for our excellent quality, reliability, and innovative service.
Basis of Presentation:
The Condensed Consolidated Financial Statements presented herein reflect the consolidated financial position as of March 31, 2020 and June 30, 2019, results of operations for the three and nine months ended March 31, 2020 and 2019, cash flows for the nine months ended March 31, 2020 and 2019, and share owners’ equity for the three and nine months ended March 31, 2020 and 2019. The financial data presented herein is unaudited and should be read in conjunction with the annual Consolidated Financial Statements as of and for the year ended June 30, 2019 and related notes thereto included in our Annual Report on Form 10-K. As such, certain information and footnote disclosures normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) have been condensed or omitted, although we believe that the disclosures are adequate to make the information presented not misleading. Intercompany transactions and balances have been eliminated. Management believes the financial statements include all adjustments (consisting only of normal recurring adjustments) considered necessary to present fairly the financial statements for the interim periods. The results of operations for the interim periods shown in this report are not necessarily indicative of results for any future interim period or for the entire fiscal year. Additionally, the impacts of the global emergence of the novel coronavirus (“COVID-19”) on our business are currently not fully known. Any prolonged economic disruption could affect demand for our customers’ products, and in turn, our services and adversely impact our results of operations and financial condition. We will continue to actively monitor the situation and take actions that may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, suppliers, and the communities in which we operate.  We cannot predict the duration or severity of the impact COVID-19 could have on our business or on our future financial results.
Revenue Recognition:
Our revenue is generated from contracts with customers primarily for manufacturing services provided for the production of electronic assemblies, components, medical disposables, and automation, test, and inspection equipment all built to customer’s specifications. Our customer agreements are generally not for a definitive term but continue for the relevant product’s life cycle. Typically, our customer agreements do not commit the customer to purchase our services until a purchase order is provided, which is generally short-term in nature. Customer purchase orders primarily have a single performance obligation. Generally, the prices stated in the customer purchase orders are agreed upon prices for the manufactured product and do not vary over the term of the order, and therefore, the majority of our contracts do not contain variable consideration. In limited circumstances, we may enter into a contract where we offer our customer a rebate once specific volume thresholds have been met; in these cases, the rebates are accounted for as variable consideration.
The majority of our revenue is recognized over time as manufacturing services are performed as we manufacture a product to customer specifications with no alternative use and we have an enforceable right to payment for performance completed to date. The remaining revenue for manufacturing services is recognized when the customer obtains control of the product, typically either upon shipment or delivery of the product dependent on the terms of the contract, and the customer is able to direct the use of and obtain substantially all of the remaining benefits from the asset. We generally recognize revenue over time using costs based input methods,

8


in which judgment is required to evaluate assumptions including the total estimated costs to determine our progress towards contract completion and to calculate the corresponding amount of revenue to recognize. Estimated costs include material, direct and indirect labor, and appropriate applied overheads. Costs based input methods are considered a faithful depiction of our efforts and progress toward satisfying our performance obligations for manufacturing services and for which we believe we are entitled to payment for performance completed to date. The cumulative effect of revisions to estimates related to net contract revenues or costs are recorded in the period in which the revisions to estimates are identified and the amounts can be reasonably estimated.
We have elected to account for shipping and handling activities related to contracts with customers as costs to fulfill our promise to transfer the associated services and products. Accordingly, we record customer payments of shipping and handling costs as a component of net sales and classify such costs as a component of cost of sales. We recognize sales net of applicable sales or value add taxes. Based on estimated product returns and price concessions, a reserve for returns and allowances is recorded at the time revenue is recognized, resulting in a reduction of net revenue.
Direct incremental costs to obtain and fulfill a contract are capitalized as a contract asset only if they are material, expected to be recovered, and are not accounted for in accordance with other guidance. Incidental items that are immaterial in the context of the contract are recognized as expense in the period incurred.
Notes Receivable and Trade Accounts Receivable:
The Company’s notes receivable and trade accounts receivable are recorded per the terms of the agreement or sale, and accrued interest is recognized when earned. We determine on a case-by-case basis the cessation of accruing interest, the resumption of accruing interest, the method of recording payments received on nonaccrual receivables, and the delinquency status for our limited number of notes receivable.
In the ordinary course of business, customers periodically negotiate extended payment terms on trade accounts receivable. Customary terms require payment within 30 to 45 days, with any terms beyond 45 days being considered extended payment terms. We may utilize accounts receivable factoring arrangements with third-party financial institutions in order to extend terms for the customer without negatively impacting our cash flow. These arrangements in all cases do not contain recourse provisions which would obligate us in the event of our customers’ failure to pay. Receivables are considered sold when they are transferred beyond the reach of Kimball Electronics and its creditors, the purchaser has the right to pledge or exchange the receivables, and we have surrendered control over the transferred receivables. In the nine months ended March 31, 2020 and 2019, we sold, without recourse, $202.0 million and $191.0 million of accounts receivable, respectively. Factoring fees were $0.4 million for both the three months ended March 31, 2020 and 2019 and $1.5 million and $1.3 million during the nine months ended March 31, 2020 and 2019, respectively. Factoring fees are recorded in Selling and Administrative Expenses on our Condensed Consolidated Statements of Income.
One of the Company’s China operations, in limited circumstances, may receive banker’s acceptance drafts from customers as payment for their trade accounts receivable. The banker’s acceptance drafts are non-interest bearing and primarily mature within six months from the origination date. The Company has the ability to sell the drafts at a discount or transfer the drafts in settlement of current accounts payable prior to the scheduled maturity date. These drafts, which totaled $4.0 million at March 31, 2020 and $4.2 million at June 30, 2019, are reflected in Receivables on the Condensed Consolidated Balance Sheets until the banker’s drafts are sold at a discount, transferred in settlement of current accounts payable, or cash is received at maturity. Banker’s acceptance drafts sold at a discount or transferred in settlement of current accounts payable during the nine months ended March 31, 2020 and 2019 were $6.5 million and $2.3 million, respectively. See Note 6 - Commitments and Contingent Liabilities of Notes to Condensed Consolidated Financial Statements for more information on banker’s acceptance drafts.
Other General Income:
Other General Income in the nine months ended March 31, 2019 included $0.1 million of pre-tax income resulting from a payment received related to a class action lawsuit in which Kimball Electronics was a class member. No Other General Income was recorded in the nine months ended March 31, 2020.
Non-operating Income (Expense), net:
Non-operating income (expense), net includes the impact of such items as foreign currency rate movements and related derivative gain or loss, fair value adjustments on supplemental employee retirement plan (“SERP”) investments, government subsidies, bank charges, and other miscellaneous non-operating income and expense items that are not directly related to operations. The gain (loss) on SERP investments is offset by a change in the SERP liability that is recognized in Selling and Administrative Expenses.

9


Components of Non-operating income (expense), net:
 
Three Months Ended
 
Nine Months Ended
 
March 31
 
March 31
(Amounts in Thousands)
2020
 
2019
 
2020
 
2019
Foreign currency/derivative gain (loss)
$
200

 
$
746

 
$
(143
)
 
$
91

Gain (loss) on SERP investments
(914
)
 
606

 
(434
)
 
99

Foreign government subsidies
58

 
9

 
123

 
580

Other
(89
)
 
(38
)
 
(218
)
 
(138
)
Non-operating income (expense), net
$
(745
)
 
$
1,323

 
$
(672
)
 
$
632

Income Taxes:
In determining the quarterly provision for income taxes, we use an estimated annual effective tax rate which is based on expected annual income, statutory tax rates, and available tax planning opportunities in the various jurisdictions in which we operate. Unusual or infrequently occurring items are separately recognized in the quarter in which they occur.
Deferred income tax assets and liabilities, recorded in Other Assets and Other long-term liabilities, respectively, in the Condensed Consolidated Balance Sheets, are recognized for the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. These assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which the temporary differences are expected to reverse. We evaluate the recoverability of deferred tax assets each quarter by assessing the likelihood of future taxable income and available tax planning strategies that could be implemented to realize our deferred tax assets. If recovery is not likely, we provide a valuation allowance based on our best estimate of future taxable income in the various taxing jurisdictions and the amount of deferred taxes ultimately realizable. Future events could change management’s assessment.
We operate within multiple taxing jurisdictions and are subject to tax audits in these jurisdictions. These audits can involve complex uncertain tax positions, which may require an extended period of time to resolve. A tax benefit from an uncertain tax position may be recognized only if it is more likely than not that the tax position will be sustained on examination by taxing authorities, based on the technical merits of the position. We maintain a liability for uncertain income tax and other tax positions, including accrued interest and penalties on those positions. As tax positions are effectively settled, the tax liability is adjusted accordingly. We recognize interest and penalties related to unrecognized tax benefits in Provision for Income Taxes on the Condensed Consolidated Statements of Income.
The U.S. Tax Cuts and Jobs Act (“Tax Reform”) was enacted into law on December 22, 2017. Tax Reform made broad and complex changes to the U.S. tax code, for which complete guidance may have not yet been issued. Tax Reform changes included, but were not limited to, (i) reducing the U.S. corporate statutory tax rate, (ii) requiring a one-time transition tax on certain unremitted earnings of foreign subsidiaries that is payable over an eight-year period, (iii) eliminating U.S. federal income taxes on dividends from foreign subsidiaries, and (iv) bonus depreciation that will allow for full expensing of qualifying property. As of March 31, 2020 and June 30, 2019, the remaining provision recorded for the one-time deemed repatriation tax was $9.8 million, payable through fiscal year 2026, and is recorded in Long-term income taxes payable on the Condensed Consolidated Balance Sheets.
On March 27, 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into law making several changes to the Internal Revenue Code. The changes include, but are not limited to: increasing the limitation on the amount of deductible interest expense, allowing companies to carry back certain net operating losses, and increasing the amount of net operating loss carryforwards the corporations can use to offset taxable income. The tax law changes in the Act did not have a material impact on the Company’s Provision for Income Taxes for the three or nine months ended March 31, 2020.
New Accounting Standards:
Adopted in fiscal year 2020:
In February 2016, the Financial Accounting Standards Board (“FASB”) issued guidance on leases with subsequent amendments to this new guidance in January 2018, July 2018, and December 2018. The new guidance requires lessees to recognize assets and liabilities on the balance sheet for the rights and obligations created by those leases and requires additional qualitative and quantitative disclosures. Under previous guidance, only capital leases were recognized on the balance sheet. We adopted this standard on July 1, 2019, the beginning of our first quarter of fiscal year 2020, under the modified retrospective method. As allowed by the July 2018 amendment, the Company has not recast the comparative periods.

10


We elected the “package of practical expedients,” which permits us not to reassess under the new standard our prior conclusions about lease identification, classification, and initial direct costs. We also elected the short-term lease recognition exemption, permitting us not to recognize right-of-use assets and lease liabilities for leases with a term of 12 months or less and do not include a purchase option whose exercise is reasonably certain.
Lease assets and liabilities are initially recognized based on the present value of lease payments over the lease term calculated using our estimated incremental borrowing rate, unless the implicit rate is readily determinable. The estimated incremental borrowing rate is the rate of interest we would have to pay on a collateralized basis to borrow an amount equal to the lease payments under similar terms. Lease terms include options to extend or terminate the lease when it is reasonably certain that those options will be exercised.
The adoption resulted in the recognition of $2.6 million of right-of-use assets and lease liabilities on our Condensed Consolidated Balance Sheet, primarily for our real estate operating leases. The adoption did not have a material effect on our results of operations or cash flows. There was no cumulative-effect adjustment to equity. See Note 14 - Leases of Notes to Condensed Consolidated Financial Statements for more information on leases.
In August 2017, the FASB issued guidance on Derivatives and Hedging. The pronouncement expands and refines hedge accounting, aligns the recognition and presentation of the effects of hedging instruments and hedge items in the financial statements, and includes certain targeted improvements to ease the application of current guidance related to the assessment of hedge effectiveness. The Company adopted this during the first quarter of fiscal year 2020 with an immaterial effect on our Condensed Consolidated Financial Statements.
Not Yet Adopted:
In June 2016, the FASB issued guidance on the Measurement of Credit Losses on Financial Instruments, which replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The guidance is effective for fiscal years beginning after December 15, 2019 and early adoption is permitted. We plan to adopt this standard effective July 1, 2020 and do not expect the adoption will have a material effect on our consolidated financial statements.
In August 2018, the FASB issued guidance on Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement. This new guidance amends the accounting for implementation, setup, and other upfront costs incurred in a cloud computing hosting arrangement. The amendment aligns the requirement for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software. The amendment also requires companies to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, including options to extend the agreement that is in control of the customer. The guidance is effective for fiscal years beginning after December 15, 2019 and interim periods within those fiscal years. Early adoption is permitted. The guidance is to be adopted either retrospectively or prospectively to all implementation costs incurred after the date of adoption. We plan to adopt prospectively effective July 1, 2020 and do not expect the adoption of this standard will have a material effect on our consolidated financial statements.
In December 2019, the FASB issued guidance on Simplifying the Accounting for Income Taxes, intended to simplify various aspects related to the accounting for income taxes. The guidance is effective for fiscal years beginning after December 15, 2020 and for interim periods within those fiscal years. Early adoption is permitted. We are currently evaluating the impact of the adoption of this guidance on our consolidated financial statements.
Note 2. Acquisition
On October 1, 2018, the Company completed the acquisition of GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., and its subsidiaries (collectively referred to as “GES”). The acquisition included purchasing substantially all of the assets and assuming certain liabilities of GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., GES Infotek Pvt. Ltd., (India), GES Japan KK, Global Equipment Services and Manufacturing (Suzhou) Co., Ltd., (China), Suzhou Global Equipment Services and Trading Co., Ltd. (China), and acquiring 100% of the capital stock of Global Equipment Services & Manufacturing Vietnam Company Limited.
This acquisition supported the Company’s strategy for growth and diversification into a multifaceted manufacturing solutions company. GES specializes in design, production, and servicing of automation, test, and inspection equipment for industrial applications in the semiconductor, electronics, and life sciences industries.

11


Incremental costs directly related to the acquisition has totaled $1.9 million, which were expensed as incurred and were recorded in Selling and Administrative Expenses on our Condensed Consolidated Statements of Income. These costs incurred during the three and nine months ended March 31, 2020 and 2019 were not material. The operating results of this acquisition are included in the Company’s consolidated financial statements beginning on the acquisition date of October 1, 2018.
The GES acquisition was accounted for as a business combination. The Company has recorded a net adjusted purchase price of $42.4 million which includes a reduction for an estimated net working capital adjustment of $7.6 million. The net working capital adjustment as provided for in the agreement is being disputed by the sellers of GES and is continuing to be resolved through the dispute resolution procedure provided for under the terms of the asset purchase agreement.
Cash paid, net of cash acquired, was $43.9 million, and a net receivable due from the seller was recognized for $3.8 million. The acquisition was primarily funded with the Company’s primary credit facility. The Company determined this acquisition is not a significant subsidiary.
The following table summarizes the final purchase price allocation to assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date, with the excess allocated to goodwill. Measurement period adjustments during the first quarter of fiscal year 2020 included a reduction of $2.0 million to Property and Equipment as a result of additional information obtained related to the valuation of certain equipment as of the acquisition date and a $0.2 million reduction in Other long-term liabilities to adjust deferred tax liabilities on the equipment. These measurement period adjustments to the purchase price allocation in the first quarter of fiscal year 2020 increased Goodwill by $1.8 million. The twelve-month measurement period ended on September 30, 2019. Adjustments after the measurement period related to the purchase price allocation, specifically as it relates to an adjustment for the final resolution of the net working capital adjustment, as applicable, will be recorded in earnings during the period of resolution and will not be reflected in goodwill. For tax purposes, $4.5 million of the goodwill recorded is expected to be deductible.
(Amounts in Thousands)
October 1, 2018
Cash
$
2,257

Receivables
15,656

Inventories
6,454

Prepaid expenses and other current assets
1,424

Property and Equipment
7,037

Other Intangible Assets
19,259

Other Assets
498

Goodwill
13,745

Total assets acquired
$
66,330

 
 
Borrowings under Credit Facilities
$
12,843

Accounts payable
4,113

Accrued expenses
1,340

Other long-term liabilities
5,653

Total liabilities assumed
$
23,949

Net assets acquired
$
42,381

Income tax liabilities, indirect tax liabilities, and liabilities for unrecognized tax benefits, including interest and penalties, of $4.2 million were recorded related to pre-closing tax periods of Global Equipment Services & Manufacturing Vietnam Company Limited of which $3.9 million was recorded in Other long-term liabilities and $0.3 million was included in Accrued expenses. This reflects management’s best assessment of the estimated taxes, interest, and penalties as of the acquisition date that are more likely than not to be paid, or for indirect taxes the probable amounts due to the tax authorities, including interest and penalties, under the applicable laws in the various jurisdictions.  Because of the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is significantly different from our current estimate of the tax liabilities. Included in Receivables was a related indemnification asset of $4.2 million for these estimated tax liabilities. The seller has agreed to indemnify the Company in the purchase agreements for all taxes allocable to all pre-closing tax periods.

12


Other Intangible Assets include the estimated fair values for finite-lived intangible assets acquired and are listed in the table below along with their estimated useful lives which are being amortized on a straight-line basis.
(Amounts in Thousands)
Estimated
Fair Value
 
Estimated useful life
(years)
Software
$
379

 
3 to 7
Technology
5,060

 
5
Trade name
6,369

 
10
Customer relationships
7,451

 
15
 
$
19,259

 
 

Note 3. Revenue from Contracts with Customers
The following table disaggregates our revenue by end market vertical for the three and nine months ended March 31, 2020 and 2019.
 
Three Months Ended
 
Nine Months Ended
 
March 31
 
March 31
(Amounts in Millions)
2020
 
2019
 
2020
 
2019
Vertical Markets:
 
 
 
 
 
 
 
Automotive
$
124.4

 
$
127.3

 
$
383.7

 
$
345.6

Medical
87.1

 
99.1

 
274.1

 
267.0

Industrial
65.6

 
68.0

 
196.7

 
187.6

Public Safety
12.5

 
15.1

 
44.2

 
50.1

Other
4.3

 
4.0

 
15.7

 
12.9

Total net sales
$
293.9

 
$
313.5

 
$
914.4

 
$
863.2

For the three months ended March 31, 2020 and 2019, approximately 88% and 68% of our net sales, respectively, were recognized over time as manufacturing services were performed under a customer contract on a product with no alternative use and we have an enforceable right to payment for performance completed to date. For the nine months ended March 31, 2020 and 2019, approximately 75% and 70% of our net sales, respectively, were recognized over time. The remaining sales revenues were primarily recognized at a point in time when the customer obtained control of the manufactured product.
The timing differences of revenue recognition, billings to our customers, and cash collections from our customers result in billed accounts receivable and unbilled accounts receivable. Contract assets on the Condensed Consolidated Balance Sheets relate to unbilled accounts receivable and occur when revenue is recognized over time as manufacturing services are provided and the billing to the customer has not yet occurred as of the balance sheet date, which are generally transferred to receivables in the next fiscal quarter due to the short-term nature of the manufacturing cycle. Contract assets were $69.5 million and $51.9 million as of March 31, 2020 and June 30, 2019, respectively.
In limited circumstances, the Company may receive payments from customers in advance of the satisfaction of performance obligations primarily for tooling or other miscellaneous services or costs. These advance payments are recognized as contract liabilities until the performance obligations are completed and are included in Accrued expenses on the Condensed Consolidated Balance Sheets, which amounted to $4.5 million and $6.3 million as of March 31, 2020 and June 30, 2019, respectively.


13


Note 4. Inventories
Inventories were valued using the lower of first-in, first-out (“FIFO”) cost and net realizable value. Inventory components were as follows:
(Amounts in Thousands)
March 31, 2020
 
June 30, 2019
Finished products
$
3,100

 
$
2,708

Work-in-process
6,468

 
4,119

Raw materials
189,393

 
197,013

Total inventory
$
198,961

 
$
203,840

Note 5. Accumulated Other Comprehensive Income (Loss)
During the nine months ended March 31, 2020 and 2019, the changes in the balances of each component of Accumulated Other Comprehensive Income (Loss), net of tax, were as follows:
Accumulated Other Comprehensive Income (Loss)
 
 
 
 
 
 
(Amounts in Thousands)
Foreign Currency Translation Adjustments
 
Derivative Gain (Loss)
 
Post Employment Benefits
Net Actuarial Gain (Loss)
 
Accumulated Other Comprehensive Income (Loss)
Balance at June 30, 2019
$
(6,848
)
 
$
(1,598
)
 
$
818

 
$
(7,628
)
Other comprehensive income (loss) before reclassifications
(3,004
)
 
(2,757
)
 
(135
)
 
(5,896
)
Reclassification to (earnings) loss
—

 
(1,144
)
 
(231
)
 
(1,375
)
Net current-period other comprehensive income (loss)
(3,004
)
 
(3,901
)
 
(366
)
 
(7,271
)
Balance at March 31, 2020
$
(9,852
)
 
$
(5,499
)
 
$
452

 
$
(14,899
)
 
 
 
 
 
 
 
 
Balance at June 30, 2018
$
(4,357
)
 
$
(3,379
)
 
$
837

 
$
(6,899
)
Other comprehensive income (loss) before reclassifications
(3,717
)
 
1,970

 
282

 
(1,465
)
Reclassification to (earnings) loss
—

 
(452
)
 
(264
)
 
(716
)
Net current-period other comprehensive income (loss)
(3,717
)
 
1,518

 
18

 
(2,181
)
Balance at March 31, 2019
$
(8,074
)
 
$
(1,861
)
 
$
855

 
$
(9,080
)

14


The following reclassifications were made from Accumulated Other Comprehensive Income (Loss) to the Condensed Consolidated Statements of Income:
Reclassifications from Accumulated Other Comprehensive Income (Loss)
Three Months Ended
 
Nine Months Ended
 
Affected Line Item in the Condensed Consolidated Statements of Income
March 31
 
March 31
 
(Amounts in Thousands)
2020
 
2019
 
2020
 
2019
 
Derivative gain (loss) (1)
$
124

 
$
571

 
$
1,434

 
$
541

 
Cost of Sales
 
—

 
(10
)
 
—

 
5

 
Non-operating income (expense), net
 
(25
)
 
(110
)
 
(290
)
 
(94
)
 
Benefit (Provision) for Income Taxes
 
$
99

 
$
451

 
$
1,144

 
$
452

 
Net of Tax
Postemployment Benefits:
 
 
 
 
 
 
 
 
 
  Amortization of actuarial gain (2)
100

 
120

 
305

 
348

 
Non-operating income (expense), net
 
(24
)
 
(29
)
 
(74
)
 
(84
)
 
Benefit (Provision) for Income Taxes
 
$
76

 
$
91

 
$
231

 
$
264

 
Net of Tax
Total reclassifications for the period
$
175

 
$
542

 
$
1,375

 
$
716

 
Net of Tax
Amounts in parentheses indicate reductions to income.
(1) See Note 9 - Derivative Instruments of Notes to Condensed Consolidated Financial Statements for further information on derivative instruments.
(2) See Note 11 - Postemployment Benefits of Notes to Condensed Consolidated Financial Statements for further information on postemployment benefit plans.
Note 6. Commitments and Contingent Liabilities
Standby letters of credit may be issued to third-party suppliers and insurance institutions and can only be drawn upon in the event of the Company’s failure to pay its obligations to a beneficiary. As of March 31, 2020, we had a maximum financial exposure from unused standby letters of credit totaling $0.4 million. We don’t expect circumstances to arise that would require us to perform under any of these arrangements and believe that the resolution of any claims that might arise in the future, either individually or in the aggregate, would not materially affect our Condensed Consolidated Financial Statements. Accordingly, no liability has been recorded as of March 31, 2020 with respect to the standby letters of credit. The Company also may enter into commercial letters of credit to facilitate payments to vendors and from customers.
One of the Company’s China operations, in limited circumstances, receives banker’s acceptance drafts from customers as settlement for their trade accounts receivable. We in turn may transfer the acceptance drafts to a supplier of ours in settlement of current accounts payable. These drafts contain certain recourse provisions afforded to the transferee under laws of The People’s Republic of China. If a transferee were to exercise its available recourse rights, the draft would revert back to our China operation and we would be required to satisfy the obligation with the transferee. At March 31, 2020, the drafts transferred and outstanding totaled $5.9 million. No transferee has exercised their recourse rights against us. For additional information on banker’s acceptance drafts, see Note 1 – Business Description and Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements.
The Company provides only assurance-type warranties for a limited time period, which cover workmanship and assures the product complies with specifications provided by or agreed upon with the customer. We maintain a provision for limited warranty repair or replacement of products manufactured and sold, which has been established in specific manufacturing contract agreements. We estimate product warranty liability at the time of sale based on historical repair or replacement cost trends in conjunction with the length of the warranty offered. Management refines the warranty liability periodically based on changes in historical cost trends and in certain cases where specific warranty issues become known.

15


Changes in the product warranty accrual for the nine months ended March 31, 2020 and 2019 were as follows:
 
Nine Months Ended
 
March 31
(Amounts in Thousands)
2020
 
2019
Product warranty liability at the beginning of the period
$
958

 
$
656

Additions to warranty accrual (including changes in estimates)
(269
)
 
40

Settlements made (in cash or in kind)
(30
)
 
(40
)
Product warranty liability at the end of the period
$
659

 
$
656

Note 7. Credit Facilities
Credit facilities consisted of the following:
 
Unused Borrowings at
 
Borrowings Outstanding at
 
Borrowings Outstanding at
(Amounts in Millions, in U.S Dollar Equivalents)
March 31, 2020
 
March 31, 2020
 
June 30, 2019
Primary credit facility (1) 
$
33.8

 
$
115.8

 
$
122.8

Thailand overdraft credit facility
2.8

 
—

 
—

China revolving credit facility
7.5

 
—

 
—

Netherlands revolving credit facility
3.5

 
6.6

 
3.4

Poland revolving credit facility
16.5

 
—

 
—

Total credit facilities
$
64.1

 
$
122.4

 
$
126.2

Less: current portion
 
 
$
(30.9
)
 
$
(34.7
)
Long-term debt under credit facilities, less current portion (2)


 
$
91.5

 
$
91.5

(1)
At March 31, 2020, the Company maintains a U.S. primary credit facility (the “primary facility”) dated as of July 27, 2018 and scheduled to mature in July 2023. The primary facility provides for $150 million in borrowings, with an option to increase the amount available for borrowing to $225 million upon request, subject to the consent of each lender participating in such increase. This facility is maintained for working capital and general corporate purposes of the Company including capital expenditures and potential acquisitions. A commitment fee is payable on the unused portion of the credit facility at a rate that ranges from 20.0 to 25.0 basis points per annum as determined by the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA, as defined in the primary facility. Types of borrowings available on the primary facility include revolving loans, multi-currency term loans, and swingline loans.
The interest rate on borrowings is dependent on the type of borrowings and will be one of the two options:
•
the London Interbank Offered Rate (“LIBOR”) in effect two business days prior to the advance (adjusted upwards to reflect bank reserve costs) for such interest period as defined in the agreement, plus the Eurocurrency Loans spread which can range from 125.0 to 175.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA; or
•
the Alternate Base Rate (“ABR”), which is defined as the highest of the fluctuating rate per annum equal to the higher of
a.
JPMorgan’s prime rate;
b.
1% per annum above the Adjusted LIBOR Rate (as defined in the Credit Agreement); or
c.
1/2 of 1% per annum above the Federal Funds Effective Rate (as defined in the Credit Agreement);
plus the ABR Loans spread which can range from 25.0 to 75.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA.

16


The Company’s financial covenants under the primary credit facility require:
•
a ratio of consolidated total indebtedness minus unencumbered U.S. cash on hand in the United States in excess of $15 million to adjusted consolidated EBITDA, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be greater than 3.0 to 1.0, and
•
a fixed charge coverage ratio, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be less than 1.1 to 1.0.
The Company had $0.4 million in letters of credit contingently committed against the credit facility at March 31, 2020.
(2)
The amount of Long-term debt, less current maturities at March 31, 2020 reflects the borrowings on the primary facility that the Company intends, and has the ability, to refinance for a period longer than twelve months.
The weighted-average interest rate on the borrowings outstanding under the credit facilities at March 31, 2020 was 3.4%.
Note 8. Fair Value
The Company categorizes assets and liabilities measured at fair value into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas level 3 generally requires significant management judgment. The three levels are defined as follows:
•
Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.
•
Level 2: Observable inputs other than those included in level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
•
Level 3: Unobservable inputs reflecting management’s own assumptions about the inputs used in pricing the asset or liability.
There were no changes in the inputs or valuation techniques used to measure fair values during the nine months ended March 31, 2020. For more information on inputs and fair valuation techniques used, refer to our Annual Report on Form 10-K for the year ended June 30, 2019.

17


Recurring Fair Value Measurements:
As of March 31, 2020 and June 30, 2019, the fair values of financial assets and liabilities that are measured at fair value on a recurring basis using the market approach are categorized as follows:
 
March 31, 2020
(Amounts in Thousands)
Level 1
 
Level 2
 
Total
Assets
 
 
 
 
 
Cash equivalents
$
1,138

 
$
—

 
$
1,138

Derivatives: foreign exchange contracts
—

 
1,016

 
1,016

Trading securities: mutual funds held in nonqualified SERP
9,132

 
—

 
9,132

Total assets at fair value
$
10,270

 
$
1,016

 
$
11,286

Liabilities
 

 
 

 
 

Derivatives: foreign exchange contracts
$
—

 
$
4,642

 
$
4,642

Total liabilities at fair value
$
—

 
$
4,642

 
$
4,642

 
 

 
 

 
 

 
June 30, 2019
(Amounts in Thousands)
Level 1
 
Level 2
 
Total
Assets
 
 
 
 
 
Cash equivalents
$
1,123

 
$
—

 
$
1,123

Derivatives: foreign exchange contracts
—

 
1,832

 
1,832

Trading securities: mutual funds held in nonqualified SERP
9,268

 
—

 
9,268

Total assets at fair value
$
10,391

 
$
1,832

 
$
12,223

Liabilities
 

 
 

 
 

Derivatives: foreign exchange contracts
$
—

 
$
299

 
$
299

Total liabilities at fair value
$
—

 
$
299

 
$
299

We had no level 3 assets or liabilities measured at fair value during the nine months ended March 31, 2020.
The nonqualified supplemental employee retirement plan (“SERP”) assets consist primarily of equity funds, balanced funds, bond funds, and a money market fund. The SERP investment assets are offset by a SERP liability which represents the Company’s obligation to distribute SERP funds to participants. See Note 10 - Investments of Notes to Condensed Consolidated Financial Statements for further information regarding the SERP.
Financial Instruments Not Carried At Fair Value:
Financial instruments that are not reflected in the Condensed Consolidated Balance Sheets at fair value that have carrying amounts which approximate fair value include notes receivable and borrowings under credit facilities. There were no changes to the inputs and valuation techniques used to assess the fair value of these financial instruments during the nine months ended March 31, 2020. For more information on inputs and fair valuation techniques used, refer to our Annual Report on Form 10-K for the year ended June 30, 2019.
The carrying value of our cash deposit accounts, trade accounts receivable, and trade accounts payable approximates fair value due to the relatively short maturity and immaterial non-performance risk.


18


Note 9. Derivative Instruments
Foreign Exchange Contracts:
We operate internationally and are therefore exposed to foreign currency exchange rate fluctuations in the normal course of business. Our primary means of managing this exposure is to utilize natural hedges, such as aligning currencies used in the supply chain with the sale currency. To the extent natural hedging techniques do not fully offset currency risk, we use derivative instruments with the objective of reducing the residual exposure to certain foreign currency rate movements. Factors considered in the decision to hedge an underlying market exposure include the materiality of the risk, the volatility of the market, the duration of the hedge, the degree to which the underlying exposure is committed to, and the availability, effectiveness, and cost of derivative instruments. Derivative instruments are only utilized for risk management purposes and are not used for speculative or trading purposes.
We use forward contracts designated as cash flow hedges to protect against foreign currency exchange rate risks inherent in forecasted transactions denominated in a foreign currency. Foreign exchange contracts are also used to hedge against foreign currency exchange rate risks related to intercompany balances denominated in currencies other than the functional currencies. As of March 31, 2020, we had outstanding foreign exchange contracts to hedge currencies against the U.S. dollar in the aggregate notional amount of $31.9 million and to hedge currencies against the Euro in the aggregate notional amount of 68.8 million Euro. The notional amounts are indicators of the volume of derivative activities but may not be indicators of the potential gain or loss on the derivatives.
In limited cases due to unexpected changes in forecasted transactions, cash flow hedges may cease to meet the criteria to be designated as cash flow hedges. Depending on the type of exposure hedged, we may either purchase a derivative contract in the opposite position of the undesignated hedge or may retain the hedge until it matures if the hedge continues to provide an adequate offset in earnings against the currency revaluation impact of foreign currency denominated liabilities.
The fair value of outstanding derivative instruments is recognized on the balance sheet as a derivative asset or liability. When derivatives are settled with the counterparty, the derivative asset or liability is relieved and cash flow is impacted for the net settlement. For derivative instruments that meet the criteria of hedging instruments under FASB guidance, the gain or loss on the derivative instrument is initially recorded net of related tax effect in Accumulated Other Comprehensive Income (Loss), a component of Share Owners’ Equity, and are subsequently reclassified into earnings in the period or periods during which the hedged transaction is recognized in earnings. The gain or loss associated with derivative instruments that are not designated as hedging instruments or that cease to meet the criteria for hedging under FASB guidance is also reported immediately in Non-operating income (expense), net on the Condensed Consolidated Statements of Income.
Based on fair values as of March 31, 2020, we estimate that approximately $4.6 million of a pre-tax derivative loss deferred in Accumulated Other Comprehensive Loss will be reclassified into earnings, along with the earnings effects of related forecasted transactions, within the next 12 months. Losses on foreign exchange contracts are generally offset by gains in operating income in the income statement when the underlying hedged transaction is recognized in earnings. Because gains or losses on foreign exchange contracts fluctuate partially based on currency spot rates, the future effect on earnings of the cash flow hedges alone is not determinable, but in conjunction with the underlying hedged transactions, the result is expected to be a decline in currency risk. The maximum length of time we had hedged our exposure to the variability in future cash flows was 12 months as of both March 31, 2020 and June 30, 2019.
See Note 8 - Fair Value of Notes to Condensed Consolidated Financial Statements for further information regarding the fair value of derivative assets and liabilities and the Condensed Consolidated Statements of Comprehensive Income for the changes in deferred derivative gains and losses. Information on the location and amounts of derivative fair values in the Condensed Consolidated Balance Sheets and derivative gains and losses in the Condensed Consolidated Statements of Income are presented below.
We adopted a new accounting standard effective July 1, 2019 which eliminated the requirement to separately measure and report hedge ineffectiveness. See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements for more information on the adoption of this new accounting standard.

19


Fair Value of Derivative Instruments on the Condensed Consolidated Balance Sheets
 
Asset Derivatives
 
Liability Derivatives
 
 
 
Fair Value As of
 
 
 
Fair Value As of
(Amounts in Thousands)
Balance Sheet Location
 
March 31,
2020
 
June 30,
2019
 
Balance Sheet Location
 
March 31,
2020
 
June 30,
2019
Derivatives Designated as Hedging Instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
Prepaid expenses and other current assets
 
$
222

 
$
1,136

 
Accrued expenses
 
$
4,642

 
$
278

 
 
 
 

 
 

 
 
 
 

 
 

Derivatives Not Designated as Hedging Instruments:
 
 

 
 
 
 

 
 

Foreign exchange contracts
Prepaid expenses and other current assets
 
794

 
696

 
Accrued expenses
 
—

 
21

Total derivatives
 
 
$
1,016

 
$
1,832

 
 
 
$
4,642

 
$
299

The Effect of Derivative Instruments on Other Comprehensive Income (Loss)
 
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
 
 
March 31
 
March 31
(Amounts in Thousands)
 
 
 
2020
 
2019
 
2020
 
2019
Amount of Pre-Tax Gain or (Loss) Recognized in Other Comprehensive Income (Loss) (OCI) on Derivatives:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
 
 
$
(5,171
)
 
$
748

 
$
(3,592
)
 
$
2,487

The Effect of Derivative Instruments on Condensed Consolidated Statements of Income
 
 
 
 
Three Months Ended
 
Nine Months Ended
(Amounts in Thousands)
 
 
 
March 31
 
March 31
Derivatives in Cash Flow Hedging Relationships
 
Location of Gain or (Loss) 
 
2020
 
2019
 
2020
 
2019
Amount of Pre-Tax Gain or (Loss) Reclassified from Accumulated OCI into Income:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
Cost of Sales
 
$
124

 
$
571

 
$
1,434

 
$
541

Foreign exchange contracts
 
Non-operating income (expense)
 
—

 
(10
)
 
—

 
5

Total
 
 
 
$
124

 
$
561

 
$
1,434

 
$
546

 
 
 
 
 
 
 
 
 
 
 
Derivatives Not Designated as Hedging Instruments
 
 
 
 

 
 

 
 
 
 
Amount of Pre-Tax Gain or (Loss) Recognized in Income on Derivatives:
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
Non-operating income (expense)
 
$
972

 
$
1,346

 
$
2,032

 
$
2,838

 
 
 
 
 

 
 

 
 
 
 
Total Derivative Pre-Tax Gain (Loss) Recognized in Income
 
$
1,096

 
$
1,907

 
$
3,466

 
$
3,384



20


Note 10. Investments
The Company maintains a self-directed supplemental employee retirement plan (“SERP”) for executive and other key employees. The Company SERP utilizes a rabbi trust, and therefore assets in the SERP portfolio are subject to creditor claims in the event of bankruptcy. The Company recognizes SERP investment assets on the balance sheet at current fair value. A SERP liability of the same amount is recorded on the balance sheet representing an obligation to distribute SERP funds to participants. The SERP investment assets are classified as trading, and accordingly, realized and unrealized gains and losses are recognized in income in the other income (expense) category. Adjustments made to revalue the SERP liability are also recognized in income as selling and administrative expenses and offset valuation adjustments on SERP investment assets. The increase/(decrease) in net unrealized holding gains for the nine months ended March 31, 2020 and 2019 was approximately, in millions, $(0.6) and $(0.2), respectively.
SERP asset and liability balances applicable to Kimball Electronics participants were as follows:
(Amounts in Thousands)
March 31,
2020
 
June 30,
2019
SERP investments - current asset
$
1,789

 
$
1,728

SERP investments - other long-term asset
7,343

 
7,540

    Total SERP investments
$
9,132

 
$
9,268

 
 
 
 
SERP obligation - current liability
$
1,789

 
$
1,728

SERP obligation - other long-term liability
7,343

 
7,540

    Total SERP obligation
$
9,132

 
$
9,268

Note 11. Postemployment Benefits
The Company maintains severance plans for all domestic employees and other statutory required postemployment plans for certain foreign subsidiaries. The domestic severance plans provide severance benefits to eligible employees meeting the plans’ qualifications, primarily involuntary termination without cause. The foreign postemployment plans include local pension, retirement, or severance plans. There are no statutory requirements for us to contribute to the plans, nor do employees contribute to the plans. The plans hold no assets. Benefits are paid using available cash on hand when eligible employees meet plan qualifications for payment. The net periodic postemployment benefit costs were not material for the nine months ended March 31, 2020 and 2019. Unusual or non-recurring severance actions are not estimable using actuarial methods and are expensed in accordance with the applicable U.S. GAAP.
 
 
 
 
 
Note 12. Stock Compensation Plans
The Company maintains a stock compensation plan, the Kimball Electronics, Inc. 2014 Stock Option and Incentive Plan (the “Plan”), which allows for the issuance of up to 4.5 million shares and may be awarded in the form of incentive stock options, stock appreciation rights, restricted shares, unrestricted shares, restricted share units, or performance shares and performance units. The Plan is a ten-year plan with no further awards allowed to be made under the Plan after October 1, 2024. The Plan was re-approved by the Company’s Share Owners at its annual meeting on November 7, 2019. The Company also maintains a nonqualified deferred stock compensation plan, the Kimball Electronics, Inc. Non-Employee Directors Stock Compensation Deferral Plan (the “Deferral Plan”), which allows Non-Employee Directors of the Company’s Board of Directors (the “Board”) to elect to defer all, or a portion of, their retainer fees in stock until retirement or termination from the Board or death. The Deferral Plan allows for issuance of up to 1.0 million shares of the Company’s common stock. For more information on the Plan and the Deferral Plan, refer to our Annual Report on Form 10-K for the year ended June 30, 2019.

21


During the first nine months of fiscal year 2020, the following stock compensation was awarded under the Plan and the Deferral Plan.
Stock Compensation Awarded
 
Quarter Awarded
 
Shares/Units
 
Grant Date Fair Value (2)
Long-Term Performance Shares (1)
 
1st Quarter
 
252,878

 

$14.39

 
 
 
 

 

Unrestricted shares (3)
 
1st Quarter
 
500

 

$14.39

 
 
 
 
 
 
 
Unrestricted shares (3)
 
2nd Quarter
 
3,758

 

$17.30

 
 
 
 
 
 
 
Deferred share units (4)
 
2nd Quarter
 
32,950

 

$17.30

(1) Long-term performance shares were awarded to officers and other key employees. Payouts will be based upon a combination of a bonus percentage attainment component calculated under the Company’s profit sharing incentive bonus plan, adjusted to a three-year average bonus percentage, and a growth attainment component, which is the Company’s growth in sales revenue based on comparison of its three-year compounded annual growth rate (“CAGR”) with the Electronics Manufacturing Services Industry’s three-year CAGR. The long-term performance shares awarded are based on three successive annual performance measurement periods, with each annual tranche having a grant date when economic profit tiers are established and approved by the Compensation and Governance Committee of the Board near the beginning of the applicable fiscal year and a vesting date shortly after the end of each annual period. The number of shares issued will be less than the maximum shares issuable if one or both of the above-mentioned incentive metric maximum thresholds are not obtained.
(2) The grant date fair value is based on the stock price at the date of the award and for long-term performance shares is applicable to the first tranche only.
(3) Unrestricted shares were awarded to a non-employee member of the Board during the second quarter of fiscal year 2020 as compensation for the portion of director’s annual retainer fees as a result of the directors’ election to be paid in unrestricted shares in lieu of cash payment or deferred share units. Director’s fees are expensed over the period that directors earn the compensation. Unrestricted shares were also awarded to a key employee during the first quarter of fiscal year 2020 which were expensed immediately. Unrestricted shares do not have vesting periods, holding periods, restrictions on sales, or other restrictions.
(4) Deferred share units were awarded to non-employee members of the Board as compensation for the portion of director’s annual retainer fees as a result of directors’ elections to receive deferred share units in lieu of cash payment or unrestricted shares. Director’s fees are expensed over the period that directors earn the compensation. Deferred share units are participating securities and are payable in common stock in a lump sum or installments in accordance with deferral elections upon a Director’s retirement or termination from the Board or death.
Note 13. Goodwill and Other Intangible Assets
A summary of goodwill is as follows:
(Amounts in Thousands)
 
 
Balance as of June 30, 2019
 
 
Goodwill
 
$
30,930

Accumulated impairment
 
(12,826
)
Goodwill, net
 
18,104

Goodwill, Additions
 
1,832

Balance as of March 31, 2020
 
 
Goodwill
 
32,762

Accumulated impairment
 
(12,826
)
Goodwill, net
 
$
19,936


22


During the first quarter of fiscal year 2020, we added $1.8 million to goodwill resulting from measurement period adjustments to the purchase price allocation of the GES acquisition. See Note 2 - Acquisition of Notes to Condensed Consolidated Financial Statements for more information on this acquisition.
A summary of other intangible assets subject to amortization is as follows:
 
March 31, 2020
 
June 30, 2019
(Amounts in Thousands)
Cost
 
Accumulated
Amortization
 
Net Value
 
Cost
 
Accumulated
Amortization
 
Net Value
Capitalized Software
$
31,889

 
$
27,567

 
$
4,322

 
$
32,015

 
$
27,124

 
$
4,891

Customer Relationships
8,618

 
1,887

 
6,731

 
8,618

 
1,506

 
7,112

Technology
5,060

 
1,524

 
3,536

 
5,060

 
766

 
4,294

Trade Name
6,369

 
955

 
5,414

 
6,369

 
478

 
5,891

Other Intangible Assets
$
51,936

 
$
31,933

 
$
20,003

 
$
52,062

 
$
29,874

 
$
22,188

During the three months ended March 31, 2020 and 2019, amortization expense of other intangible assets was, in millions, $0.8 and $0.9, respectively. During the nine months ended March 31, 2020 and 2019, amortization expense of other intangible assets was, in millions, $2.4 and $1.8, respectively.
The estimated useful life of internal-use software ranges from 3 years to 10 years. The amortization period for the customer relationships, technology, and trade name intangible assets is 15 years, 5 years, and 10 years, respectively. We have no intangible assets with indefinite useful lives which are not subject to amortization.
Note 14. Leases
The Company determines if a contract is or contains a lease at inception. The Company leases certain office, manufacturing, and warehouse facilities under operating leases, in addition to land on which certain office and manufacturing facilities reside. These operating leases expire from fiscal year 2020 to 2057. The Company has a minimal number of finance leases with an immaterial impact on its Condensed Consolidated Financial Statements.
Operating lease costs for the three and nine months ended March 31, 2020 were $0.3 million and $0.9 million, respectively, including short-term and variable lease costs. Cash payments for operating leases included in the measurement of lease liabilities for the nine months ended March 31, 2020 were $0.6 million, which is included in Cash Flows from Operating Activities in the Condensed Consolidated Statement of Cash Flows.
The lease assets and liabilities, which exclude leases with terms of 12 months or less, as of March 31, 2020 were as follows:
(Amounts in Thousands)
 
Operating lease right-of-use assets (included in Other Assets)
$
2,041

Operating lease liability, current (included in Accrued expenses)
$
761

Operating lease liability, noncurrent (included in Other long-term liabilities)
$
1,280

Weighted average remaining lease term in years - operating leases
5.0

Weighted average discount rate - operating leases
3.4
%

23


Future lease payments as of March 31, 2020 are as follows:
(Amounts in Thousands)
 
2020 (1)
$
182

2021
740

2022
592

2023
95

2024
95

Thereafter
475

Total undiscounted lease payments
$
2,179

Less: imputed interest
138

Total lease liabilities
$
2,041

(1) Represents estimated lease payments for the remaining three-month period ending June 30, 2020.
As reported under the previous lease accounting standard, the aggregate future minimum rental payments on our operating leases, as of June 30, 2019, were, in millions, $0.8, $0.7, $0.6, $0.1, and $0.1 for the five years ending June 30, 2024, respectively, and $0.5 million thereafter.
Note 15. Share Owners’ Equity
On October 21, 2015, the Board authorized an 18-month stock repurchase plan (the “Stock Repurchase Plan”) allowing a repurchase of up to $20 million worth of common stock. Then, separately on each of September 29, 2016, August 23, 2017, and November 8, 2018, the Board extended and increased the Stock Repurchase Plan to allow the repurchase of up to an additional $20 million worth of common stock with no expiration date, which brought the total authorized stock repurchases under the Plan to $80 million. Purchases may be made under various programs, including in open-market transactions, block transactions on or off an exchange, or in privately negotiated transactions, all in accordance with applicable securities laws and regulations. The Stock Repurchase Plan may be suspended or discontinued at any time, and the Stock Repurchase Plan has been temporarily suspended as a result of the COVID-19 environment.
During the nine months ended March 31, 2020, the Company repurchased $8.8 million of common stock at an average price of $14.12 which was recorded as Treasury stock, at cost in the Condensed Consolidated Balance Sheets. Since the inception of the Stock Repurchase Plan, the Company has repurchased $76.7 million of common stock at an average cost of $14.93 per share.

24


Note 16. Earnings Per Share
Basic and diluted earnings per share were calculated as follows under the two-class method:
 
Three Months Ended
 
Nine Months Ended
 
March 31
 
March 31
(Amounts in thousands, except per share data)
2020
 
2019
 
2020
 
2019
Basic and Diluted Earnings Per Share:
 
 
 
 
 
 
 
   Net Income
$
6,259

 
$
11,849

 
$
19,469

 
$
24,033

   Less: Net Income allocated to participating securities
8

 
15

 
25

 
22

   Net Income allocated to common Share Owners
$
6,251

 
$
11,834

 
$
19,444

 
$
24,011

 
 
 
 
 
 
 
 
Basic weighted average common shares outstanding
25,181

 
25,479

 
25,308

 
25,993

Dilutive effect of average outstanding performance shares
100

 
81

 
143

 
167

Dilutive effect of average outstanding deferred stock units
6

 
8

 
15

 
21

Dilutive weighted average shares outstanding
25,287

 
25,568

 
25,466

 
26,181

 
 
 
 
 
 
 
 
Earnings Per Share of Common Stock:
 
 
 
 
 
 
 
Basic
$
0.25

 
$
0.46

 
$
0.77

 
$
0.92

Diluted
$
0.25

 
$
0.46

 
$
0.76

 
$
0.92

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Business Overview
We are a global, multifaceted manufacturing solutions provider. We provide contract electronics manufacturing services (“EMS”) and diversified manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, industrial, and public safety end markets. Our core competency is producing durable electronics, and we further offer diversified contract manufacturing services for non-electronic components, medical disposables, precision molded plastics, and production automation, test, and inspection equipment. Our manufacturing services, including engineering and supply chain support, utilize common production and support capabilities globally. We are well recognized by our customers and the industry for our excellent quality, reliability, and innovative service. For the third time in six years, we were recognized in 2020 for achieving the Highest Overall Customer Rating in CIRCUITS ASSEMBLY’s 2020 Service Excellence Awards. CIRCUITS ASSEMBLY is a leading brand and technical publication for electronics manufacturers worldwide.
The contract manufacturing services industry is very competitive. As a mid-sized player, we can expect to be challenged by the agility and flexibility of the smaller, regional players, and we can expect to be challenged by the scale and price competitiveness of the larger, global players. We enjoy a unique market position between these extremes which allows us to compete with the larger scale players for high-volume projects, but also maintain our competitive position in the generally lower volume durable electronics market space.  We expect to continue to effectively operate in this market space; however, one significant challenge will be maintaining our profit margins while we continue our revenue growth. Price increases are uncommon in the market as production efficiencies and material pricing advantages for most projects drive costs and prices down over the life of the projects.  This characteristic of the contract electronics marketplace is expected to continue.
The March 2020 edition of Manufacturing Market Insider published by NVR indicated that the group of leading EMS companies that comprise its annual list of the 50 largest EMS providers for 2019, of which we are a member, experienced revenue growth of 0.4% in calendar year 2019. During calendar year 2019, we experienced growth of approximately 13%.
We continue to monitor the current economic and industry conditions for uncertainties that may pose a threat to our future growth or cause disruption in business strategy, execution, and timing in the markets in which we compete. We are actively monitoring the global COVID-19 pandemic and its impact on all our operations, including the effect on the supply chain, the availability of critical components, and the health and availability of our workforce. Our primary focus is the well-being and safety of our employees, and we are following current guidelines suggested by applicable authorities. Because of the variety of critical medical device assemblies

25


we manufacture around the world, our facilities are classified as “essential businesses” or otherwise are currently permitted to operate under shelter in place orders or other similar orders but have been affected to varying degrees by COVID-19. Significant uncertainties and risks exist related to the severity and length of the impact of COVID-19 on our end markets, the supply chain, the health and availability of our workforce, and global macroeconomic conditions; therefore, its financial impact on our results cannot be reasonably estimated but could be material.
The COVID-19 pandemic has adversely impacted the automotive industry by disrupting the supply chain from China and leading to automakers in the U.S. and Europe temporarily suspending production. Although we experienced growth in the automotive market in the first nine months of fiscal year 2020 over the prior year nine-month period, led by the continued ramp-up of new programs including programs for fully electric vehicles, we anticipate demand will be lower in the near future as a direct result of COVID-19. In the medical market, we experienced small year-over-year growth in the first nine months of fiscal year 2020, and we anticipate further growth in the upcoming quarters as we are currently experiencing a significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products. In the industrial market, growth was driven in large part due to increased demand for smart metering products, and we expect demand to remain steady as many of our customers’ businesses have been classified as essential. 
The EMS industry has previously experienced certain component shortages and component allocations. Component shortages or allocations could increase component costs and potentially interrupt our operations and negatively impact our ability to meet commitments to customers. We have taken various actions to mitigate the risk and minimize the adverse effect the component shortages or allocations could have on our results and the impact to our customers. In addition, the impact from tariffs and additional proposed tariffs on components we utilize in our domestic manufacturing process, of which many currently can only be sourced from China, may adversely affect the competitiveness of our domestic operations.
We expect to make investments that will help us continue our development into a multifaceted manufacturing solutions provider, including through acquisitions. As discussed in Note 2 - Acquisition of Notes to Condensed Consolidated Financial Statements, we completed the acquisition of GES Holdings, Inc., Global Equipment Services and Manufacturing, Inc., and its subsidiaries (collectively referred to as “GES”) on October 1, 2018. GES specializes in design, production, and servicing of automation, test, and inspection equipment for industrial applications in the semiconductor, electronics, and life sciences industries.
We have a strong focus on cost control and closely monitor market changes and our liquidity in order to proactively adjust our operating costs and discretionary capital spending as needed. Managing working capital in conjunction with fluctuating demand levels is likewise key. In an effort to meet the increased demand for medical assemblies in the short term, we expect to increase the utilization of our existing liquidity or consider other options to enhance our liquidity. In addition, a long-standing component of our profit sharing incentive bonus plan is that it is linked to our financial performance which results in varying amounts of compensation expense as profits change.
We continue to maintain a strong balance sheet, which included a current ratio of 2.1, a debt-to-equity ratio of 0.3, and Share Owners’ equity of $375 million at March 31, 2020. Our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, some of which are uncommitted, totaled $122.4 million at March 31, 2020.
In addition to the above discussion related to the current market conditions, management currently considers the following events, trends, and uncertainties to be most important to understanding our financial condition and operating performance:
•
Due to the contract and project nature of the contract manufacturing industry, fluctuation in the demand for our products and variation in the gross margin on those programs is inherent to our business. Effective management of manufacturing capacity is, and will continue to be, critical to our success.
•
The nature of the EMS industry is such that the start-up of new customers and new programs to replace expiring programs occurs frequently. While our agreements with customers generally do not have a definitive term and thus could be canceled at any time with little or no notice, we generally realize relatively few cancellations prior to the end of the product’s life cycle. We attribute this to our focus on long-term customer relationships, meeting customer expectations, required capital investment, and product qualification cycle times. As such, our ability to continue contractual relationships with our customers, including our principal customers, is not certain. New customers and program start-ups generally cause losses early in the life of a program, which are generally recovered as the program becomes established and matures.


26


•
Risk factors within our business include, but are not limited to, general economic and market conditions, customer order delays, globalization, global health emergencies including the COVID-19 pandemic, impact related to tariffs and other trade barriers, foreign currency exchange rate fluctuations, rapid technological changes, component availability, supplier and customer financial stability, the contract nature of this industry, the concentration of sales to large customers, and the potential for customers to choose a dual sourcing strategy or to in-source a greater portion of their manufacturing. The continuing success of our business is dependent upon our ability to replace expiring customers/programs with new customers/programs. We monitor our success in this area by tracking the number of customers and the percentage of our net sales generated from them by years of service as depicted in the table below. While variation in the size of program award makes it difficult to directly correlate this data to our sales trends, we believe it does provide useful information regarding our customer loyalty and new business growth. Additional risk factors that could have an effect on our performance are located within the “Risk Factors” section of our Annual Report on Form 10-K for the year ended June 30, 2019. See Item 1A - Risk Factors of this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 for revised risk factors.
 
 
Nine Months Ended
 
 
March 31
Customer Service Years
 
2020
 
2019
More than 10 Years
 
 
 
 
% of Net Sales
 
77
%
 
76
%
# of Customers
 
39

 
30

5 to 10 Years
 
 
 
 
% of Net Sales
 
10
%
 
9
%
# of Customers
 
18

 
18

Less than 5 Years
 
 
 
 
% of Net Sales
 
13
%
 
15
%
# of Customers
 
20

 
29

Total
 
 
 
 
% of Net Sales
 
100
%
 
100
%
 # of Customers
 
77

 
77

•
Employees throughout our business operations are an integral part of our ability to compete successfully, and the stability of the management team is critical to long-term Share Owner value. Our talent management and succession planning processes help to maintain stability in management.
Certain preceding statements could be considered forward-looking statements under the Private Securities Litigation Reform Act of 1995 and are subject to certain risks and uncertainties including, but not limited to, successful integration of acquisitions and new operations, adverse changes in the global economic conditions, the geopolitical environment, global health emergencies, loss of key customers or suppliers, or similar unforeseen events. Additional information on risks is contained in our Annual Report on Form 10-K for the year ended June 30, 2019. See Item 1A - Risk Factors of this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 for revised risk factors.


27


Financial Overview

The impacts of the global emergence of COVID-19 on our business are currently not fully known. Any prolonged economic disruption could affect demand for our customers’ products, and in turn, our services and adversely impact our results of operations and financial condition.  We are conducting business as usual with some modifications to employee travel and employee work locations, among other modifications, as our facilities are classified as “essential businesses” because of the variety of critical medical device assemblies we manufacture around the world. We have observed other companies, including some of our customers, taking precautionary and preemptive actions and companies may take further actions that alter their normal business operations. We will continue to actively monitor the situation and may take further actions that alter our business operations as may be required by federal, state, or local authorities or that we determine are in the best interests of our employees, customers, suppliers, and the communities in which we operate.  It is not clear what the potential effects any such alterations or modifications may have on our business, including the effects on our customers or on our financial results for our fourth quarter of fiscal 2020.
 
At or for the
Three Months Ended
 
 
 
March 31
 
 
(Amounts in Millions, Except for Per Share Data)
2020
 
as a % of Net Sales
 
2019
 
as a % of Net Sales
 
% Change
Net Sales
$
293.9

 
 
 
$
313.5

 
 
 
(6
)%
Gross Profit
$
20.2

 
6.9
%
 
$
26.6

 
8.5
%
 
(24
)%
Selling and Administrative Expenses
$
9.6

 
3.3
%
 
$
12.1

 
3.9
%
 
(20
)%
Operating Income
$
10.6

 
3.6
%
 
$
14.5

 
4.6
%
 
(27
)%
Net Income
$
6.3

 
 
 
$
11.8

 
 
 
(47
)%
Diluted Earnings per Share
$
0.25

 
 
 
$
0.46

 
 
 
(46
)%
Open Orders
$
511.0

 
 
 
$
379.5

 
 
 
35
%
 
 
 
 
 
 
 
 
 
 
 
For the Nine Months Ended
 
 
 
March 31
 
 
(Amounts in Millions, Except for Per Share Data)
2020
 
as a % of Net Sales
 
2019
 
as a % of Net Sales
 
% Change
Net Sales
$
914.4

 
 
 
$
863.2

 
 
 
6
%
Gross Profit
$
62.9

 
6.9
%
 
$
65.2

 
7.6
%
 
(3
)%
Selling and Administrative Expenses
$
32.5

 
3.6
%
 
$
33.5

 
3.9
%
 
(3
)%
Other General Income
$
—

 
 
 
$
0.1

 
 
 
 
Operating Income
$
30.4

 
3.3
%
 
$
31.7

 
3.7
%
 
(4
)%
Net Income
$
19.5

 
 
 
$
24.0

 
 
 
(19
)%
Diluted Earnings per Share
$
0.76

 
 
 
$
0.92

 
 
 
(17
)%

28


Net Sales by Vertical Market
Three Months Ended
 
 
 
Nine Months Ended
 
 
 
March 31
 
 
 
March 31
 
 
(Amounts in Millions)
2020
 
2019
 
% Change
 
2020
 
2019
 
% Change
Automotive
$
124.4

 
$
127.3

 
(2
)%
 
$
383.7

 
$
345.6

 
11
%
Medical
87.1

 
99.1

 
(12
)%
 
274.1

 
267.0

 
3
%
Industrial
65.6

 
68.0

 
(3
)%
 
196.7

 
187.6

 
5
%
Public Safety
12.5

 
15.1

 
(18
)%
 
44.2

 
50.1

 
(12
)%
Other
4.3

 
4.0

 
8
%
 
15.7

 
12.9

 
22
%
Total Net Sales
$
293.9

 
$
313.5

 
(6
)%
 
$
914.4

 
$
863.2

 
6
%
Third quarter fiscal year 2020 consolidated net sales decreased compared to the third quarter of fiscal year 2019, driven largely by overall lower demand, and to a lesser extent, the negative impact to sales from COVID-19. Year-to-date fiscal year 2020 consolidated net sales increased compared to the year-to-date period of fiscal year 2019 primarily due to the continued ramp-up of certain programs, new product introductions, and an overall increase in demand in the first half of the fiscal year. Consolidated net sales for both the current quarter and current year-to-date period were impacted by a 1% unfavorable foreign currency exchange fluctuation when compared to the same periods in the prior year. By end market vertical, our market verticals fluctuated as follows:
•
Sales to customers in the automotive market decreased in the third quarter of fiscal year 2020 compared to the third quarter of fiscal year 2019 largely from lower demand of existing products, including the negative impact to demand from COVID-19 starting in the last part of the quarter, which was partially offset by the ramp-up of certain programs for fully electric vehicles and new product introductions. Sales to customers increased in the year-to-date period of fiscal year 2020 compared to the year-to-date period of fiscal year 2019 with overall stronger demand, the ramp-up of certain programs for fully electric vehicles, the favorable impact of certain contracts with customers beginning to meet the criteria to recognize revenue over time during the current fiscal year, which were partially offset by the unfavorable sales impact to our customers that support GM due to the UAW labor strike and the negative impact to demand from COVID-19. We anticipate demand from customers in the automotive market will be lower in the near term as a direct result of COVID-19, primarily in North America and Europe as automakers in these locations have temporarily halted production. We cannot predict the severity or the duration of this COVID-19 impact on the automotive market.
•
Sales to customers in the medical market decreased in the third quarter of fiscal year 2020 compared to the third quarter of fiscal year 2019 largely from lower overall demand that was partially offset by the ramp-up of certain products. Sales to customers in the medical market increased in the year-to-date period of fiscal year 2020 compared to the year-to-date period of fiscal year 2019 primarily due to increased demand for existing products and the continued ramp-up of certain programs. We anticipate growth of sales to customers in the medical market in the upcoming quarters as we are currently experiencing a significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products as a direct result of the COVID-19 pandemic and related global shortage of respiratory equipment.
•
Sales to customers in the industrial market declined in the third quarter of the current fiscal year when compared to the third quarter of the prior fiscal year as lower end market demand for climate control products and the phase out of certain programs were partially offset by increased demand for smart metering products. However, sales to customers in the industrial market improved in the year-to-date period of fiscal year 2020 compared to the year-to-date period of fiscal year 2019 from increased demand for smart metering products, which was partially offset by lower end market demand for climate control products and the phase out of certain programs.
•
Sales to customers in the public safety market decreased in the third quarter and year-to-date period of fiscal year 2020 compared to the third quarter and year-to-date period of fiscal year 2019 due to the phase out of certain programs and lower overall demand.

29


A significant amount of sales to Nexteer Automotive, Philips, and ZF accounted for the following portions of our net sales:
 
Three Months Ended
 
Nine Months Ended
  
March 31
 
March 31
 
2020
 
2019
 
2020
 
2019
Nexteer Automotive
16%
 
13%
 
15%
 
12%
Philips
14%
 
13%
 
14%
 
14%
ZF
*
 
12%
 
*
 
12%
 
 
 
 
 
 
 
 
* amount is less than 10% of total
 
 
 
 
 
 
 
Open orders were up 35% as of March 31, 2020 compared to March 31, 2019 as open orders in the medical and automotive markets significantly increased. The increase in open orders in the medical market are a direct result of the COVID-19 pandemic as we are currently experiencing a significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products. The increase in open orders in the automotive market is due in part to the ramp-up of new programs and certain key customers placing orders with increased lead times. Open orders are the aggregate sales price of production pursuant to unfulfilled customer orders, which may be delayed or canceled by the customer subject to contractual termination provisions. Substantially all of the open orders as of March 31, 2020 are expected to be filled within the next twelve months. Open orders at a point in time may not be indicative of future sales trends due to the contract nature of our business. Additionally, COVID-19 could impact the timing and certainty of fulfillment of open orders.
Third quarter fiscal year 2020 gross profit as a percent of net sales declined when compared to the third quarter of fiscal year 2019 primarily due to lower volumes and unfavorable product mix, which were partially offset by lower profit-sharing bonus expense. Year-to-date fiscal year 2020 gross profit as a percent of net sales declined compared to year-to-date fiscal year 2019 primarily due to unfavorable product mix and the unfavorable impact to gross profit from our recent acquisition.
Selling and administrative expenses decreased as a percent of net sales and in absolute dollars in the third quarter of fiscal year 2020 when compared to the third quarter of fiscal year 2019. The current quarter selling and administrative expenses decreased primarily from a decrease in the fair value of the liability for the supplemental employee retirement plan (“SERP”) and lower incentive-based compensation, which were partially offset by higher salary and related payroll costs.
For the first nine months of fiscal year 2020, selling and administrative expenses decreased as a percent of net sales and in absolute dollars when compared to the first nine months of fiscal year 2019 primarily from lower incentive-based compensation and a decrease in the fair value of the SERP liability, which were partially offset by higher salary and related payroll costs in addition to higher amortization expense directly resulting from the finite-lived intangible assets acquired with the GES acquisition.
Other General Income in the first nine months of fiscal year 2019 included $0.1 million of pre-tax income resulting from a payment received related to the settlement of a class action lawsuit in which Kimball Electronics was a class member. No Other General Income was recorded during the first nine months of fiscal year 2020.
Other Income (Expense) consisted of the following:
 
 
Three Months Ended
 
Nine Months Ended
 
 
March 31
 
March 31
(Amounts in Thousands)
 
2020
 
2019
 
2020
 
2019
Interest income
 
$
18

 
$
19

 
$
43

 
$
42

Interest expense
 
(1,166
)
 
(1,165
)
 
(3,523
)
 
(2,644
)
Foreign currency/derivative gain (loss)
 
200

 
746

 
(143
)
 
91

Gain (loss) on SERP investments
 
(914
)
 
606

 
(434
)
 
99

Foreign government subsidies
 
58

 
9

 
123

 
580

Other
 
(89
)
 
(38
)
 
(218
)
 
(138
)
Other income (expense), net
 
$
(1,893
)
 
$
177

 
$
(4,152
)
 
$
(1,970
)

30


Interest expense has increased in the first nine months of fiscal year 2020 compared to the first nine months of fiscal year 2019 due to increased borrowings on the credit facilities. The foreign currency/derivative gain (loss) resulted from net foreign currency exchange rate movements during the period. The revaluation to fair value of the SERP investments recorded in Other Income (Expense) is offset by the revaluation of the SERP liability recorded in Selling and Administrative Expenses, and thus there is no effect on net income.
Our income before income taxes and effective tax rate were comprised of the following U.S. and foreign components:

 
For the Nine Months Ended

 
March 31, 2020
 
March 31, 2019
(Amounts in Thousands)
 
Income Before Taxes
 
Effective Tax Rate
 
Income Before Taxes
 
Effective Tax Rate
United States
 
$
1,858

 
49.8
%
 
$
11,751

 
14.2
%
Foreign
 
24,377

 
24.0
%
 
18,020

 
22.6
%
Total
 
$
26,235

 
25.8
%
 
$
29,771

 
19.3
%
When compared to the statutory rate, the domestic effective tax rate for the first nine months of fiscal year 2020 was substantially higher as the relatively low profit before tax magnified the impact of certain discrete adjustments and tax expense due to the global intangible low-taxed income provisions of Tax Reform.
When compared to the statutory rate, the domestic effective tax rate and the consolidated effective tax rate for the first nine months of fiscal year 2019 were favorably impacted by discrete income tax adjustments related to the U.S. research and development tax credit, adjustments to provisions related to Tax Reform prior to the end of the measurement period, the excess tax benefit on stock-based compensation granted during the period, and provision to return adjustments.
Comparing the balance sheet as of March 31, 2020 to June 30, 2019, Receivables decreased $34.2 million largely due to increased utilization of our accounts receivable factoring arrangements. Contract assets, which reflect the unbilled accounts receivable that occur when we recognize revenue over time, increased $17.5 million as a result of the timing of shipments and related billings, increased production volumes, and certain contracts with customers beginning to meet the criteria to recognize revenue over time during the current fiscal year. Goodwill has increased $1.8 million due to purchase accounting measurement period adjustments associated with the GES acquisition. Treasury stock, at cost increased $6.7 million primarily due to stock repurchases under an authorized stock repurchase plan. A $7.3 million change in Accumulated other comprehensive loss was primarily driven by foreign currency translation adjustments.
Liquidity and Capital Resources
Working capital at March 31, 2020 was $281.4 million compared to working capital of $280.4 million at June 30, 2019. The current ratio was 2.1 at March 31, 2020 and 2.0 at June 30, 2019. The debt-to-equity ratio was 0.3 at both March 31, 2020 and June 30, 2019. Our short-term liquidity available, represented as cash and cash equivalents plus the unused amount of our credit facilities, some of which are uncommitted, totaled $122.4 million at March 31, 2020 and $110.7 million at June 30, 2019.

31


Cash Conversion Days (“CCD”) are calculated as the sum of Days Sales Outstanding (“DSO”) plus Contract Asset Days (“CAD”) plus Production Days Supply on Hand (“PDSOH”) less Accounts Payable Days (“APD”). CCD is a metric used to measure the efficiency of managing working capital. CCD for the quarter ended March 31, 2020 was 81 days, which increased from the quarter ended June 30, 2019 and the quarter ended March 31, 2019. The following table summarizes our CCD for the quarterly periods indicated.
 
 
Three Months Ended
 
 
March 31, 2020
 
June 30, 2019
 
March 31, 2019
DSO
 
55
 
59
 
56
CAD
 
21
 
15
 
15
PDSOH
 
67
 
64
 
68
APD
 
62
 
61
 
64
CCD
 
81
 
77
 
75
We define DSO as the average of monthly trade accounts and notes receivable divided by an average day’s net sales, CAD as the average monthly contract assets divided by an average day’s net sales, PDSOH as the average of monthly gross inventory divided by an average day’s cost of sales, and APD as the average of monthly accounts payable divided by an average day’s cost of sales.
Cash Flows
The following table reflects the major categories of cash flows for the first nine months of fiscal years 2020 and 2019.
 
 
Nine Months Ended
 
 
March 31
(Amounts in millions)
 
2020
 
2019
Net cash provided by (used for) operating activities
 
$
51.3

 
$
(19.0
)
Net cash used for investing activities
 
$
(27.6
)
 
$
(59.5
)
Net cash (used for) provided by financing activities
 
$
(13.5
)
 
$
80.3

Cash Flows from Operating Activities
Net cash provided by operating activities for the first nine months of fiscal year 2020 was largely driven by net income adjusted for non-cash items. Net cash used for operating activities in the first nine months of fiscal year 2019 was primarily driven by cash used from changes in operating assets and liabilities which more than offset the cash provided by net income adjusted for non-cash items. Changes in operating assets and liabilities provided $5.7 million of cash in the first nine months of fiscal year 2020 and used $66.2 million of cash in the first nine months of fiscal year 2019.
The cash provided of $5.7 million from changes in operating assets and liabilities in the first nine months of fiscal year 2020 is primarily due to a decrease in accounts receivable, which provided cash of $33.6 million primarily due to the increased utilization of accounts receivable factoring arrangements. Partially offsetting cash provided by accounts receivable was an increase in contract assets, which used cash of $17.5 million as a result of the timing of shipments and related billings, increased production volumes, and certain contracts with customers beginning to meet the criteria to recognize revenue over time during the current fiscal year, and cash used of $8.1 million as accrued expenses and taxes payable decreased, driven largely by a significant portion of accrued incentive compensation being paid during the first nine months of fiscal year 2020 and the reduction of advance payments from customers recognized as contract liabilities as the performance obligations were completed.
The cash used of $66.2 million from changes in operating assets and liabilities in the first nine months of fiscal year 2019 is largely due to an increase in accounts receivable, which used cash of $37.4 million primarily due to increased sales volumes, and an increase in inventory, which used cash of $43.8 million primarily to support increased production volumes and open orders, from a change in customers’ forecasts, and from additional purchases to help mitigate the potential impact from component shortages. Partially offsetting this usage was an increase in accounts payable, which provided cash of $24.3 million largely resulting from the increased inventory purchases to support increased production volumes.

32


Cash Flows from Investing Activities
For the first nine months of fiscal years 2020 and 2019, net cash used for investing activities was $27.6 million and $59.5 million, respectively. During the first nine months of fiscal year 2020, we invested $27.8 million into capital expenditures for the future primarily for machinery and equipment for capacity purposes and to support new business awards. During the first nine months of fiscal year 2019, we invested $43.9 million for the GES acquisition. See Note 2 - Acquisition of Notes to Condensed Consolidated Financial Statements for more information on cash paid, net of cash acquired, and the purchase price allocation to assets acquired and liabilities assumed for this acquisition. Also during the first nine months of fiscal year 2019, we invested $16.0 million into capital expenditures for the future primarily for machinery and equipment for capacity purposes and to support new business awards, replacement of older machinery and equipment, and improvements to our facilities.
Cash Flows from Financing Activities
For the first nine months of fiscal year 2020, net cash used by financing activities of $13.5 million resulted from net payments on our primary credit facility of $7.0 million, repurchases of our common stock under an authorized stock repurchase plan, and the remittance of tax withholdings on share-based payments, which were only partially offset by additional borrowings of $3.3 million on our Netherlands credit facility. For the first nine months of fiscal year 2019, net cash provided by financing activities of $80.3 million resulted from net borrowings on our primary credit facility of $118.8 million, partially offset by repurchases of our common stock under an authorized stock repurchase plan, the remittance of tax withholdings on share-based payments, and debt issuance costs. The borrowings on our primary credit facility in the first nine months of fiscal year 2019 were used to primarily fund the GES acquisition that occurred on October 1, 2018 in addition to other domestic cash needs. Also included in the financing activities for the first nine months of fiscal year 2019 were $12.8 million of payments on the Vietnam credit facility that was assumed with the GES acquisition.
Credit Facilities
The Company maintains a U.S. primary credit facility (the “primary facility”) that has a maturity date of July 27, 2023 and allows for up to $150 million in borrowings, with an option to increase the amount available for borrowing to $225 million at the Company’s request, subject to the consent of each lender participating in such increase.
The proceeds of the loans on the primary credit facility are to be used for working capital and general corporate purposes of the Company including capital expenditures and potential acquisitions. A portion of the credit facility, not to exceed $15 million of the principal amount, will be available for the issuance of letters of credit. A commitment fee on the unused portion of the principal amount of the credit facility is payable at a rate that ranges from 20.0 to 25.0 basis points per annum as determined by the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA.
The interest rate on borrowings is dependent on the type of borrowings and will be one of following two options:
•
the London Interbank Offered Rate (“LIBOR”) in effect two business days prior to the advance (adjusted upwards to reflect bank reserve costs) for such interest period as defined in the agreement, plus the Eurocurrency Loans spread which can range from 125.0 to 175.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA; or
•
the Alternate Base Rate (“ABR”), which is defined as the highest of the fluctuating rate per annum equal to the higher of
a.
JPMorgan’s prime rate;
b.
1% per annum above the Adjusted LIBOR Rate (as defined in the Credit Agreement); or
c.
1/2 of 1% per annum above the Federal Funds Effective Rate (as defined in the Credit Agreement);
plus the ABR Loans spread which can range from 25.0 to 75.0 basis points based on the Company’s ratio of consolidated total indebtedness to adjusted consolidated EBITDA.
At March 31, 2020, we had $115.8 million in borrowings under the primary facility and $0.4 million in letters of credit against the primary facility. Borrowings under the primary facility were used as the primary source of funding for the GES acquisition as well as for domestic cash needs. At March 31, 2020, $91.5 million of the borrowings were classified as long-term as the Company intends, and has the ability, to refinance for a period longer than twelve months. At June 30, 2019, we had $122.8 million in borrowings under the primary facility and $0.4 million in letters of credit against the primary facility.

33


The Company’s financial covenants under the primary credit facility require:
•
a ratio of consolidated total indebtedness minus unencumbered U.S. cash on hand in the United States in excess of $15 million to adjusted consolidated EBITDA, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be greater than 3.0 to 1.0, and
•
a fixed charge coverage ratio, determined as of the end of each of its fiscal quarters for the then most recently ended four fiscal quarters, to not be less than 1.1 to 1.0.
We were in compliance with the financial covenants during the nine-month period ended March 31, 2020.
Kimball Electronics has foreign credit facilities available to satisfy short-term cash needs at specific foreign locations rather than funding from intercompany sources. These foreign credit facilities can be canceled at any time by either the bank or us. As of March 31, 2020, we maintained the following foreign credit facilities:
•
A Thailand overdraft credit facility which allows for borrowings up to 90 million Thai Baht (approximately $2.8 million at March 31, 2020 exchange rates). We had no borrowings under this foreign credit facility as of March 31, 2020 or June 30, 2019.
•
An uncommitted credit facility for one of our China operations, which allows for borrowings up to $7.5 million that can be drawn in either U.S. dollars or China Renminbi. We had no borrowings outstanding under this foreign credit facility as of March 31, 2020 or June 30, 2019.
•
An uncommitted revolving credit facility for our Netherlands subsidiary, which allows for borrowings of up to 9.2 million Euro (approximately $10.1 million at March 31, 2020 exchange rates) that can be drawn in Euro, U.S. dollars, or other optional currency. We had $6.6 million in borrowings outstanding under this Netherlands revolving credit facility as of March 31, 2020 and $3.4 million as of June 30, 2019.
•
An uncommitted revolving credit facility for our Poland operation, which allows for borrowings of up to 15 million Euro (approximately $16.5 million at March 31, 2020 exchange rates) that can be drawn in Euro, U.S. dollars, or Polish Zloty. We had no borrowings under this foreign credit facility as of March 31, 2020 or June 30, 2019.
Factoring Arrangements
The Company may utilize accounts receivable factoring arrangements with third-party financial institutions in order to extend terms for the customer without negatively impacting our cash flow.  These arrangements in all cases do not contain recourse provisions which would obligate us in the event of our customers’ failure to pay.  Receivables are considered sold when they are transferred beyond the reach of Kimball Electronics and its creditors, the purchaser has the right to pledge or exchange the receivables, and we have surrendered control over the transferred receivables. In the nine months ended March 31, 2020 and 2019, we sold, without recourse, $202.0 million and $191.0 million of accounts receivable, respectively.  See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements for more information regarding the factoring arrangements.
Future Liquidity
Due to the COVID-19 pandemic, we are anticipating growth in sales to customers in the medical market in the upcoming quarters as we are currently experiencing a significant increase in demand for medical assemblies, specifically those related to respiratory care and patient monitoring products. In an effort to meet the increased demand for medical assemblies in the short term, we expect to increase the utilization of our existing liquidity or consider other options to enhance our liquidity. We are also hiring additional employees in certain locations to support the increased demand. We are in a solid financial position to be able to meet the increased demand and weather the impact of COVID-19; however, significant uncertainty and risks exist related to the severity and length of the impact to certain markets, the supply chain, and to global macroeconomic conditions.

34


We believe our principal sources of liquidity from available funds on hand, cash generated from operations, the availability of borrowing under our existing credit facilities, and opportunities to increase our available liquidity will be sufficient to meet our working capital and other operating needs for at least the next 12 months. The unused borrowings in USD equivalent under all of our credit facilities totaled $64.1 million at March 31, 2020. We expect to continue to invest in capital expenditures prudently, particularly for projects, including potential acquisitions, that would help us continue our development as a multifaceted manufacturing solutions provider.
The GES acquisition completed on October 1, 2018 was accounted for as a business combination. As of March 31, 2020, the Company has recorded a net adjusted purchase price of $42.4 million, which includes a reduction for an estimated net working capital adjustment of $7.6 million. We have paid cash, net of the cash acquired, of $43.9 million, and a net receivable due from the seller has been recognized for $3.8 million. While the net working capital adjustment has been disputed by the sellers of GES and continues to be resolved through the dispute resolution process, the purchase price is considered final as a result of the twelve-month measurement period ending on September 30, 2019.
At March 31, 2020, our capital expenditure commitments were approximately $2.2 million, consisting primarily of commitments for capacity purposes in anticipation of future growth, including new program wins, and replacement purposes. We anticipate our available liquidity will be sufficient to fund these capital expenditures. As a result of COVID-19, we expect to increase our capital investments in the upcoming quarters to expand capacities to meet the increased demand for medical assemblies.
At March 31, 2020, our foreign entities held cash totaling $56.5 million. In December 2017, the U.S. Tax Cuts and Jobs Act (“Tax Reform”) was enacted into law by the United States. Tax Reform imposed a one-time deemed repatriation tax on accumulated unremitted foreign earnings. The Company has made reasonable estimates of certain effects and, therefore, has recorded provisions for net deferred tax assets at the new applicable rate and the one-time deemed repatriation tax on accumulated unremitted foreign earnings. As of March 31, 2020, the remaining provision recorded for the one-time deemed repatriation tax was $9.8 million recorded in Long-term income taxes payable on the Condensed Consolidated Balance Sheet. The Company expects to pay this tax payable with available liquidity. Most of these accumulated unremitted foreign earnings have been invested in active non-U.S. business operations, and it is not anticipated such earnings will be remitted to the United States. Our intent is to permanently reinvest these funds outside of the United States. However, if such funds were repatriated, a portion of the funds remitted would be subject to applicable non-U.S. income and withholding taxes.
In March 2020, the Coronavirus Aid, Relief, and Economic Security (“CARES”) Act was signed into law making several changes to the Internal Revenue Code. The changes include, but are not limited to: increasing the limitation on the amount of deductible interest expense, allowing companies to carryback certain net operating losses, and increasing the amount of net operating loss carryforwards that corporations can use to offset taxable income, in addition to allowing companies to defer the payment of certain employer portion payroll taxes.  The tax law changes in the Act did not have a material impact on the Company’s financial results for the three and nine months ended March 31, 2020.
On October 21, 2015, the Company’s Board of Directors approved a resolution to authorize an 18-month stock repurchase plan (the “Plan”) to allow the repurchase of up to $20 million of common stock. Then, separately on each of September 29, 2016, August 23, 2017, and November 8, 2018, the Board extended and increased the Plan to allow the repurchase of up to an additional $20 million worth of common stock with no expiration date, which brought the total authorized stock repurchases under the Plan to $80 million. The Plan may be suspended or discontinued at any time and has been temporarily suspended as a result of the COVID-19 environment. The extent to which the Company repurchases its shares, and the timing of such repurchases, will depend upon a variety of factors, including market conditions, regulatory requirements, and other corporate considerations, as determined by the Company’s management team. The Company expects to finance the purchases with existing liquidity. The Company has repurchased $76.7 million of common stock under the Plan through March 31, 2020.
Our ability to generate cash from operations to meet our liquidity obligations could be adversely affected in the future by factors such as general economic and market conditions, lack of availability of raw material components in the supply chain, a decline in demand for our services, loss of key contract customers, unsuccessful integration of acquisitions and new operations, the ability of Kimball Electronics to generate profits, the length and severity of the COVID-19 pandemic and the related uncertainty around the financial impact, global health emergencies, and other unforeseen circumstances. In particular, should demand for our customers’ products and, in turn, our services decrease significantly over the next 12 months, the available cash provided by operations could be adversely impacted.
The preceding statements include forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.

35


Fair Value
During the third quarter of fiscal year 2020, no level 1 or level 2 financial instruments were affected by a lack of market liquidity. For level 1 financial assets, readily available market pricing was used to value the financial instruments. Our foreign currency derivative assets and liabilities, which were classified as level 2, were independently valued using observable market inputs such as forward interest rate yield curves, current spot rates, and time value calculations. To verify the reasonableness of the independently determined fair values, these derivative fair values were compared to fair values calculated by the counterparty banks. Our own credit risk and counterparty credit risk had an immaterial impact on the valuation of the foreign currency derivatives. See Note 8 - Fair Value of Notes to Condensed Consolidated Financial Statements for additional information.
Contractual Obligations
There have been no material changes outside the ordinary course of business to Kimball Electronics’ summary of contractual obligations under the caption, “Contractual Obligations” in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” of our Annual Report on Form 10-K for the year ended June 30, 2019.
Off-Balance Sheet Arrangements
In limited circumstances, we receive banker’s acceptance drafts from customers to one of our China operations. In turn, we may transfer the acceptance drafts to a supplier in settlement of current accounts payable. These drafts contain certain recourse provisions afforded to the transferee under laws of The People’s Republic of China, and if exercised, our China operation would be required to satisfy the obligation with the transferee as the draft would revert back to our China operation. No transferee has exercised their recourse rights against us. We also have standby letters of credit entered into in the normal course of business.
These arrangements do not have a material current effect and are not reasonably likely to have a material future effect on our financial condition, results of operations, liquidity, capital expenditures, or capital resources. See Note 1 – Business Description and Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements for more information on the banker’s acceptance drafts and Note 6 - Commitments and Contingent Liabilities of Notes to Condensed Consolidated Financial Statements for more information on standby letters of credit. We do not have material exposures to trading activities of non-exchange traded contracts.
The preceding statements are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Certain factors could cause actual results to differ materially from forward-looking statements.
Critical Accounting Policies
Kimball Electronics’ Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America. These principles require the use of estimates and assumptions that affect amounts reported and disclosed in the Condensed Consolidated Financial Statements and related notes. Actual results could differ from these estimates and assumptions. Management uses its best judgment in the assumptions used to value these estimates, which are based on current facts and circumstances, prior experience, and other assumptions that are believed to be reasonable.
There have been no material changes to our critical accounting policies since our Annual Report on Form 10-K for the year ended June 30, 2019. For further information regarding our critical accounting policies, refer to “Note 1 - Business Description and Summary of Significant Accounting Policies” of Notes to Consolidated Financial Statements and “Critical Accounting Policies” in the section entitled “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our Annual Report on Form 10-K for the year ended June 30, 2019.
New Accounting Standards
See Note 1 - Business Description and Summary of Significant Accounting Policies of Notes to Condensed Consolidated Financial Statements for information regarding New Accounting Standards.


36


Forward-Looking Statements
Certain statements contained within this document are considered forward-looking under the Private Securities Litigation Reform Act of 1995. The statements may be identified by the use of words such as “believes,” “anticipates,” “expects,” “intends,” “plans,” “projects,” “estimates,” “forecasts,” “seeks,” “likely,” “future,” “may,” “might,” “should,” “would,” “will,” and similar expressions. These forward-looking statements are subject to risks and uncertainties including, but not limited to, successful integration of acquisitions and new operations, adverse changes in global economic conditions, the geopolitical environment, global health emergencies including the COVID-19 pandemic, significant reductions in volumes and order patterns from key contract customers, loss of key customers or suppliers within specific industries, financial stability of key customers and suppliers, availability or cost of raw materials and components, the ability of the supply chain to react successfully to significant increases in demand for certain medical components, impact related to tariffs and other trade barriers, increased competitive pricing pressures, foreign exchange fluctuations, changes in the regulatory environment, or similar unforeseen events. Additional cautionary statements regarding other risk factors that could have an effect on the future performance of Kimball Electronics are contained in our Annual Report on Form 10-K for the year ended June 30, 2019. See Item 1A - Risk Factors of this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020 for revised risk factors.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
There were no material changes in our exposure to market risks for changes in foreign currency exchange rates and interest rates as compared to the fiscal year ended June 30, 2019. The interest rate on certain borrowings under our U.S. primary credit facility and our foreign credit facilities are based on LIBOR. The United Kingdom’s Financial Conduct Authority announced that after 2021 it would no longer persuade or compel panel banks to submit the rates required to calculate LIBOR, and it is unclear whether the banks currently reporting information used to set LIBOR will stop doing so after 2021. The Company is monitoring these developments.
Comprehensive disclosures of quantitative and qualitative market risk can be found in our Annual Report on Form 10-K for the year ended June 30, 2019.
Item 4. Controls and Procedures
(a)
Evaluation of disclosure controls and procedures.
Kimball Electronics maintains controls and procedures designed to ensure that information required to be disclosed in the reports that are filed or submitted under the Securities Exchange Act of 1934 is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based upon their evaluation of those controls and procedures performed as of March 31, 2020, our Chief Executive Officer and Chief Financial Officer concluded that the disclosure controls and procedures were effective.
(b)
Changes in internal control over financial reporting.
The Company is continuously seeking to improve the efficiency and effectiveness of its operations and of its internal control over financial reporting. During the quarter ended March 31, 2020, the Company implemented a new group consolidation system. As a result, new processes and controls have been implemented, as necessary, to provide management with a reasonable assurance of accuracy and integrity in the Company’s financial results and reporting. Other than for the implementation of the new group consolidation system, there have been no changes in our internal control over financial reporting that occurred during the quarter ended March 31, 2020 that have materially affected, or that are reasonably likely to materially affect, our internal control over financial reporting.

37


PART II. OTHER INFORMATION
Item 1. Legal Proceedings
We may, from time to time, be involved in legal proceedings arising in the normal course of business. Other than proceedings incidental to our business, we are not a party to, nor is any of our property the subject of, any material pending legal proceedings and no such proceedings are, to our knowledge, threatened against us.
Item 1A. Risk Factors
We are subject to various risks and uncertainties in the course of our business. A comprehensive disclosure of risk factors related to Kimball Electronics can be found in our Annual Report on Form 10-K. We are including the following revised risk factors to update and supersede the corresponding risk factors disclosed in our Annual Report on Form 10-K for the year ended June 30, 2019, and the revised risk factors should be read in conjunction with the risk factors disclosed in our Annual Report on Form 10-K for the year ended June 30, 2019. In addition, many of our other risk factors could be exacerbated by the COVID-19 pandemic and any worsening of the global business and economic environment as a result. For more information on our forward-looking statements, see the “Forward-Looking Statements” section of Item 2 - Management’s Discussion and Analysis of Financial Condition and Results of Operations of this Quarterly Report on Form 10-Q for the quarter ended March 31, 2020.
Natural disasters or other catastrophic events such as the COVID-19 pandemic may impact our production schedules and, in turn, negatively impact profitability.
Natural disasters or other catastrophic events, including severe weather, terrorist attacks, power interruptions, fires, and pandemics, could disrupt operations and likewise our ability to produce or deliver products.  Our manufacturing operations require significant amounts of energy, including natural gas and oil, and governmental regulations may control the allocation of such fuels to Kimball Electronics.  Employees are an integral part of our business, and events such as a pandemic could reduce the availability of employees reporting for work. In the event we experience a temporary or permanent interruption in our ability to produce or deliver product, revenues could be reduced, and business could be materially adversely affected. In addition, catastrophic events, or the threat thereof, can adversely affect U.S. and world economies, and could result in reduced demand for our customers’ products and delayed or lost revenue for our services. Further, any continuing disruption in our computer systems could adversely affect the ability to receive and process customer orders, manufacture products, and ship products on a timely basis, and could adversely affect relations with customers, potentially resulting in reduction in orders from customers or loss of customers. We maintain insurance to help protect us from costs relating to some of these matters, but such may not be sufficient or paid in a timely manner to us in the event of such an interruption.
For example, the COVID-19 pandemic has impacted and will continue to impact our global operations. We have experienced and are experiencing sales declines in certain product categories, especially in the automotive market as a result of temporary suspensions of production by automakers. Several of our facilities have experienced closures due to the COVID-19 outbreak. While some facilities have since resumed normal operations, further closures could occur. All of our operations have been, and will continue to be, impacted to varying degrees by government measures to contain or mitigate the spread of the virus, including travel restrictions, restrictions on operation of businesses, shelter in place orders, and mandatory closures of schools and child-care facilities, which in turn can have adverse impacts on the availability of critical components, capacity utilization at our facilities, and the ability of certain employees to return to work. We cannot predict the duration or scope of the COVID-19 pandemic; therefore, its financial impact on our financial position, results of operations, and cash flows cannot be reasonably estimated but could be material.

38



Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
The following table contains information about our purchases of equity securities during the three months ended March 31, 2020.
 
 
 
 
 
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plan
Maximum Dollar Value of Shares that May Yet Be Purchased Under the Plan(1)(2)
January 1, 2020 - January 31, 2020
—
$
—

—
$
5,977,717

February 1, 2020 - February 29, 2020
24,959
$
14.60

24,959
$
5,613,243

March 1, 2020 - March 31, 2020
188,737
$
12.30

188,737
$
3,292,453

Total
213,696
$
12.57

213,696
 
(1) On October 21, 2015, our Board of Directors (the “Board”) approved an 18-month stock repurchase plan (the “Plan”), authorizing the repurchase of up to $20 million worth of our common stock.
(2) Separately on each of September 29, 2016, August 23, 2017, and November 8, 2018, the Board extended and increased the Plan to allow the repurchase of up to an additional $20 million worth of common stock with no expiration date, which brought the total authorized stock repurchases under the Plan to $80 million. On March 30, 2020, the Plan was temporarily suspended as a result of the COVID-19 environment.

39


Item 6. Exhibits
Exhibits (numbered in accordance with Item 601 of Regulation S-K)
3.1
 
3.2
 
31.1(a)
 
31.2(a)
 
32.1(a)(b)
 
32.2(a)(b)
 
101.INS(a)
 
XBRL Instance Document
101.SCH(a)
 
XBRL Taxonomy Extension Schema Document
101.CAL(a)
 
XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF(a)
 
XBRL Taxonomy Extension Definition Linkbase Document
101.LAB(a)
 
XBRL Taxonomy Extension Label Linkbase Document
101.PRE(a)
 
XBRL Taxonomy Extension Presentation Linkbase Document
 
(a)  Filed herewith
(b)  In accordance with Item 601(b)(32)(ii) of Regulation S-K, the certifications furnished in Exhibit 32.1 and 32.2 will not be
deemed “filed” for purposes of Section 18 of the Exchange Act. Such certifications will not be deemed to be incorporated by
reference into any filing under the Securities Act or the Exchange Act, except to the extent that the registrant specifically
incorporates it by reference.




40


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 
 
KIMBALL ELECTRONICS, INC.
 
 
 
 
By:
/s/ DONALD D. CHARRON
 
 
Donald D. Charron
Chairman of the Board,
Chief Executive Officer
 
 
May 5, 2020
 
 
 
 
 
 
 
By:
/s/ MICHAEL K. SERGESKETTER
 
 
Michael K. Sergesketter
Vice President,
Chief Financial Officer
 
 
May 5, 2020

41

Kimball Electronics, Inc. Reports